Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	supramolecular fiber organization	MAPT MARCKSL1 DYSF ADD1 MAP3K1 AXIN1 BLOC1S6 P3H1 PIK3R2 SSH3 MICAL3 ARHGAP25 CAMSAP1 LTBP4 GOLGA2 ARAP1 SHANK1 CARMIL2 PLEKHG2 NCKAP5L SHANK3 ARHGEF10L GAS2L1 RFLNB MAP1S KASH5 MICALL2 MICAL2 MARCKS MYBPC3	2.41e-08	957	205	30	GO:0097435
GeneOntologyBiologicalProcess	actin filament organization	MARCKSL1 ADD1 MAP3K1 BLOC1S6 PIK3R2 SSH3 MICAL3 ARHGAP25 ARAP1 SHANK1 CARMIL2 PLEKHG2 SHANK3 ARHGEF10L GAS2L1 RFLNB KASH5 MICALL2 MICAL2 MARCKS	1.93e-07	509	205	20	GO:0007015
GeneOntologyBiologicalProcess	actin filament-based process	MARCKSL1 ARHGEF17 ADD1 MAP3K1 BLOC1S6 ADRB1 PIK3R2 SSH3 MICAL3 ARHGAP25 ARAP1 SHANK1 CARMIL2 HCN4 SHC1 PLEKHG2 SHANK3 SYDE1 ARHGEF10L SLC4A2 GAS2L1 RFLNB KASH5 MICALL2 MICAL2 MARCKS MYBPC3	4.04e-07	912	205	27	GO:0030029
GeneOntologyBiologicalProcess	actin cytoskeleton organization	MARCKSL1 ARHGEF17 ADD1 MAP3K1 BLOC1S6 PIK3R2 SSH3 MICAL3 ARHGAP25 ARAP1 SHANK1 CARMIL2 SHC1 PLEKHG2 SHANK3 SYDE1 ARHGEF10L SLC4A2 GAS2L1 RFLNB KASH5 MICALL2 MICAL2 MARCKS MYBPC3	4.51e-07	803	205	25	GO:0030036
GeneOntologyBiologicalProcess	protein depolymerization	DYSF ADD1 MICAL3 CAMSAP1 CARMIL2 NCKAP5L GAS2L1 MAP1S MICAL2	1.42e-05	144	205	9	GO:0051261
GeneOntologyBiologicalProcess	negative regulation of cytoskeleton organization	DYSF ADD1 MAP3K1 SSH3 CAMSAP1 ARAP1 SHANK1 CARMIL2 SHANK3 GAS2L1	2.54e-05	194	205	10	GO:0051494
GeneOntologyBiologicalProcess	actin filament bundle organization	ADD1 MAP3K1 BLOC1S6 PIK3R2 ARAP1 SHANK1 SHANK3 ARHGEF10L RFLNB MARCKS	2.66e-05	195	205	10	GO:0061572
GeneOntologyBiologicalProcess	negative regulation of supramolecular fiber organization	DYSF ADD1 MAP3K1 SSH3 CAMSAP1 ARAP1 SHANK1 CARMIL2 SHANK3 GAS2L1	2.90e-05	197	205	10	GO:1902904
GeneOntologyBiologicalProcess	regulation of supramolecular fiber organization	MAPT DYSF ADD1 MAP3K1 PIK3R2 SSH3 CAMSAP1 ARAP1 SHANK1 CARMIL2 PLEKHG2 SHANK3 ARHGEF10L GAS2L1 MAP1S	3.45e-05	438	205	15	GO:1902903
GeneOntologyBiologicalProcess	regulation of cytoskeleton organization	MAPT DYSF ADD1 MAP3K1 PIK3R2 SSH3 CAMSAP1 ARAP1 SHANK1 CARMIL2 PLEKHG2 SHANK3 SYDE1 ARHGEF10L SLC4A2 GAS2L1 MAP1S	7.13e-05	579	205	17	GO:0051493
GeneOntologyBiologicalProcess	cognition	MAPT SERPINF1 ZZEF1 PGRMC1 CIC BLOC1S6 TTBK1 ADRB1 GNAS SHANK1 CACNA1E HTR6 SHANK3 ANKRD11	9.09e-05	423	205	14	GO:0050890
GeneOntologyBiologicalProcess	actin filament bundle assembly	ADD1 MAP3K1 BLOC1S6 PIK3R2 ARAP1 SHANK1 SHANK3 ARHGEF10L MARCKS	1.29e-04	191	205	9	GO:0051017
GeneOntologyBiologicalProcess	regulation of actin filament-based process	ADD1 MAP3K1 ADRB1 PIK3R2 SSH3 ARAP1 SHANK1 CARMIL2 HCN4 PLEKHG2 SHANK3 ARHGEF10L SLC4A2 MYBPC3	1.31e-04	438	205	14	GO:0032970
HumanPheno	Abnormal atrioventricular valve morphology	PKD1L1 THSD1 RREB1 PPP1R13L ZNF469 UBE2A PIK3R2 ALPK3 METTL27 HCN4 KMT2D ANKRD11 EHMT1 SMARCA4 LTBP3 PRDM16	7.75e-06	350	67	16	HP:0006705
HumanPheno	Abnormal mitral valve morphology	THSD1 PPP1R13L ZNF469 UBE2A PIK3R2 ALPK3 METTL27 HCN4 KMT2D ANKRD11 SMARCA4 LTBP3 PRDM16	2.22e-05	257	67	13	HP:0001633
HumanPheno	Abnormal heart valve physiology	THSD1 PPP1R13L CIC ZNF469 UBE2A PIK3R2 ALPK3 METTL27 DPH2 HCN4 KMT2D ANKRD11 EHMT1 SMARCA4 LTBP3 PRDM16	4.56e-05	403	67	16	HP:0031653
Domain	SH3	TSPOAP1 EPS8L1 PPP1R13L STAC2 CASKIN2 PIK3R2 CASKIN1 MAP3K9 SKAP2 SHANK1 SHANK3	2.77e-05	216	205	11	SM00326
Domain	SH3	TSPOAP1 EPS8L1 PPP1R13L STAC2 CASKIN2 PIK3R2 CASKIN1 MAP3K9 SKAP2 SHANK1 SHANK3	2.77e-05	216	205	11	PS50002
Domain	SH3_domain	TSPOAP1 EPS8L1 PPP1R13L STAC2 CASKIN2 PIK3R2 CASKIN1 MAP3K9 SKAP2 SHANK1 SHANK3	3.28e-05	220	205	11	IPR001452
Domain	SH3_2	TSPOAP1 STAC2 CASKIN2 CASKIN1 MAP3K9 SHANK1 SHANK3	4.47e-05	86	205	7	PF07653
Domain	SH3_2	TSPOAP1 STAC2 CASKIN2 CASKIN1 MAP3K9 SHANK1 SHANK3	4.47e-05	86	205	7	IPR011511
Domain	SAM	CASKIN2 CASKIN1 ARAP1 SHANK1 SAMD4B DGKD SHANK3	5.19e-05	88	205	7	SM00454
Domain	RhoGAP	ARHGAP30 PIK3R2 ARHGAP25 ARAP1 SYDE1 ARHGAP45	5.99e-05	62	205	6	SM00324
Domain	RhoGAP	ARHGAP30 PIK3R2 ARHGAP25 ARAP1 SYDE1 ARHGAP45	6.56e-05	63	205	6	PF00620
Domain	RhoGAP_dom	ARHGAP30 PIK3R2 ARHGAP25 ARAP1 SYDE1 ARHGAP45	7.17e-05	64	205	6	IPR000198
Domain	RHOGAP	ARHGAP30 PIK3R2 ARHGAP25 ARAP1 SYDE1 ARHGAP45	7.17e-05	64	205	6	PS50238
Domain	-	ARHGAP30 PIK3R2 ARHGAP25 ARAP1 SYDE1 ARHGAP45	7.17e-05	64	205	6	1.10.555.10
Domain	SAM_DOMAIN	CASKIN2 CASKIN1 ARAP1 SHANK1 SAMD4B DGKD SHANK3	8.46e-05	95	205	7	PS50105
Domain	SAM	CASKIN2 CASKIN1 ARAP1 SHANK1 SAMD4B DGKD SHANK3	9.66e-05	97	205	7	IPR001660
Domain	SAM_1	CASKIN2 CASKIN1 ARAP1 SHANK1 SAMD4B SHANK3	1.01e-04	68	205	6	PF00536
Domain	Caskin_C	CASKIN2 CASKIN1	1.20e-04	2	205	2	IPR032117
Domain	MARCKS	MARCKSL1 MARCKS	1.20e-04	2	205	2	IPR002101
Domain	MARCKS_1	MARCKSL1 MARCKS	1.20e-04	2	205	2	PS00826
Domain	MARCKS_2	MARCKSL1 MARCKS	1.20e-04	2	205	2	PS00827
Domain	Caskin-tail	CASKIN2 CASKIN1	1.20e-04	2	205	2	PF16632
Domain	MARCKS	MARCKSL1 MARCKS	1.20e-04	2	205	2	PF02063
Domain	CH	ASPM MICAL3 CAMSAP1 GAS2L1 MICALL2 MICAL2	1.50e-04	73	205	6	PS50021
Domain	-	CASKIN2 CASKIN1 ARAP1 SHANK1 SAMD4B DGKD SHANK3	1.69e-04	106	205	7	1.10.150.50
Domain	CH-domain	ASPM MICAL3 CAMSAP1 GAS2L1 MICALL2 MICAL2	1.74e-04	75	205	6	IPR001715
Domain	SAM/pointed	CASKIN2 CASKIN1 ARAP1 SHANK1 SAMD4B DGKD SHANK3	3.10e-04	117	205	7	IPR013761
Domain	Anion_exchange_CS	SLC4A3 SLC4A2	3.57e-04	3	205	2	IPR018241
Domain	Rho_GTPase_activation_prot	ARHGAP30 PIK3R2 ARHGAP25 ARAP1 SYDE1 ARHGAP45	4.17e-04	88	205	6	IPR008936
Domain	FERM_f0	SHANK1 SHANK3	7.09e-04	4	205	2	PF16511
Domain	DEK_C	SSH3 DEK	7.09e-04	4	205	2	PF08766
Domain	DEK_C	SSH3 DEK	7.09e-04	4	205	2	IPR014876
Domain	FERM_f0	SHANK1 SHANK3	7.09e-04	4	205	2	IPR032425
Domain	CH	ASPM MICAL3 GAS2L1 MICALL2 MICAL2	7.35e-04	65	205	5	SM00033
Domain	PH_dom-like	EPS8L1 ARHGEF17 AFAP1L2 PLEKHM2 PHLPP1 ARHGAP25 SKAP2 ARAP1 SHC1 DGKD PLEKHG2 ARHGEF10L TNS4	8.88e-04	426	205	13	IPR011993
Domain	CH	ASPM MICAL3 GAS2L1 MICALL2 MICAL2	1.03e-03	70	205	5	PF00307
Domain	-	ASPM MICAL3 GAS2L1 MICALL2 MICAL2	1.10e-03	71	205	5	1.10.418.10
Domain	Anion_exchange	SLC4A3 SLC4A2	1.17e-03	5	205	2	IPR001717
Domain	-	ARHGEF17 AFAP1L2 PLEKHM2 PHLPP1 ARHGAP25 SKAP2 ARAP1 SHC1 DGKD PLEKHG2 ARHGEF10L TNS4	1.33e-03	391	205	12	2.30.29.30
Pathway	REACTOME_RHO_GTPASE_CYCLE	ARHGAP30 ARHGEF17 PRAG1 TXNL1 PIK3R2 ARHGAP25 GOLGA2 ARAP1 ESYT1 RAPGEF1 PLEKHG2 SYDE1 ARHGEF10L WDR6 ARHGAP45	1.26e-05	439	130	15	MM15595
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	VWA5B2 ZXDC RIN3 PCNX3 CARD10 DYSF ZZEF1 PRAG1 REXO1 GADD45A CIC PRR12 TNRC18 WIZ PLEKHM2 CASKIN1 TMCC2 MCM3AP TMEM132A PDZD8 RIPOR1 MICAL3 ZNF579 CAMSAP1 DMWD LTBP4 METTL27 ARAP1 RAD9A DPH2 B4GALNT4 ESYT1 ZNF316 SHC1 LMTK2 RAPGEF1 RHOT2 SMG5 FBXO46 ARHGEF10L C6orf132 HIVEP3 NHSL1 GAS2L1 KMT2D AATK MAP1S SLC45A3 ZNF335 HELZ2 ANKRD11 EHMT1 LTBP3 PRDM16 RAB11FIP3	3.00e-32	1105	230	55	35748872
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	PDE4C AKAP8 MAPT MCM2 RREB1 PGRMC1 CCNK REXO1 CIC ADD1 ZBTB7A USP42 RIPOR1 MICAL3 ZNF579 DMWD WDR62 SAMD4B DDX51 AKT1S1 PITPNM1 USP10 KMT2D GTF3C1 MAP1S PRICKLE3 ZNF335 HELZ2 SMARCA4	5.81e-14	774	230	29	15302935
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CDK18 AARS1 AKAP8 MAPT N4BP3 ARHGEF17 PRAG1 CIC CASKIN2 MAP3K9 GNAS CAMSAP1 WNK4 WDR62 CARMIL2 ESYT1 SAMD4B LMTK2 PLEKHG2 NCKAP5L AKT1S1 SYDE1 C6orf132 NHSL1 ANKRD11	7.54e-10	861	230	25	36931259
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	AARS1 CARD10 CIC ZBTB7A TNRC18 AFAP1L2 USP42 CASKIN2 USP4 ZNF579 SAMD4B CGAS ZNF316 SHC1 SHANK3 SYDE1 NHSL1 ZNF335 JRK	2.00e-07	689	230	19	36543142
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	REXO1 PRR12 KRBA1 TNRC18 TTBK1 TMCC2 TMEM132A MICAL3 ARHGAP25 SEC14L1 ZNF473 DGKD SHANK3 HIVEP3 HELZ2 PRDM16	2.23e-07	493	230	16	15368895
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	AKAP8 MAPT RREB1 ZZEF1 SLC35G1 ZBTB7A ZNF469 WIZ PIK3R2 MCM3AP ASPM ZNF579 LTBP4 WDR62 ZNF316 RHOT2 NCKAP5L FOXP4 WDR6 IL21R EHMT1 SMARCA4 ZFHX3 PRDM16	4.63e-07	1116	230	24	31753913
Pubmed	A directed protein interaction network for investigating intracellular signal transduction.	ZXDC RIN3 PRAG1 PGRMC1 GADD45A CIC ADD1 UBE2A WIZ SULT1A3 MCM3AP RIPOR1 USP4 NR1H2 ZNF579 QARS1 GOLGA2 ARAP1 RAD9A SHC1 APLP1 DGKD AKT1S1 GTF3C1	5.25e-07	1124	230	24	21900206
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	TSPOAP1 CIC MAP3K1 ZNF469 TNRC18 PIK3R2 CAMSAP1 WNK4 ARAP1 MGRN1 BEAN1 C6orf132 AATK MAP1S	1.25e-06	430	230	14	35044719
Pubmed	MICALs, a family of conserved flavoprotein oxidoreductases, function in plexin-mediated axonal repulsion.	MICAL3 MICALL2 MICAL2	2.83e-06	5	230	3	12110185
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	ASXL1 TMCC2 PHLPP1 CHD6 ARAP1 SMG5 AATK HELZ2 EHMT1 PRDM16	2.85e-06	225	230	10	12168954
Pubmed	Interaction network of human early embryonic transcription factors.	RREB1 PRR12 TNRC18 WIZ MCM3AP FOXP4 KMT2D WDR6 EHMT1 SMARCA4 ZFHX3 PRDM16	4.43e-06	351	230	12	38297188
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	TSPOAP1 CIC HOXA7 PRR12 AFAP1L2 ATP11B MICAL3 GNAS FLVCR1 SPDYE18 HEXIM1 KMT2D ZNF335 HELZ2 TNS4	4.76e-06	552	230	15	10737800
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RREB1 RBBP8NL CIC PRR12 TXNL1 WIZ CHD6 CAMSAP1 WDR62 KMT2D GTF3C1 WDR6 ZFHX3	4.95e-06	418	230	13	34709266
Pubmed	Loss of Wiz Function Affects Methylation Pattern in Palate Development and Leads to Cleft Palate.	ETV4 AXIN1 WIZ EHMT1	6.68e-06	19	230	4	34150743
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CDK18 AKAP8 UNC5B MARCKSL1 PGRMC1 ADD1 TXNL1 CASKIN2 P3H1 PIK3R2 ASPM PDZD8 GNAS DEK WDR62 DPH2 ESYT1 FLVCR1 NCKAP5L SLC4A2 USP10 WDR6 SLC19A1 ANKRD11 EHMT1 MARCKS	6.79e-06	1487	230	26	33957083
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	UNC5B MARCKSL1 AFAP1L2 PTPRG CASKIN2 PPP1R37 MICAL3 CAMSAP1 CARMIL2 FLVCR1 RAPGEF1 SLC4A2 MICAL2 SLC19A1 MARCKS	6.84e-06	569	230	15	30639242
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	CCNK CIC PRR12 TXNL1 TNRC18 WIZ HEXIM1 FOXP4 KMT2D SMARCA4	1.32e-05	268	230	10	33640491
Pubmed	PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase.	AKAP8 ZZEF1 PIK3R2 ASPM WDR62 HEXIM1 MAP1S SMARCA4 ARHGAP45	4.32e-05	247	230	9	32989298
Pubmed	Enhanced Muscular Dystrophy from Loss of Dysferlin Is Accompanied by Impaired Annexin A6 Translocation after Sarcolemmal Disruption.	DYSF LTBP4	4.35e-05	2	230	2	27070822
Pubmed	Control of lung development by latent TGF-β binding proteins.	LTBP4 LTBP3	4.35e-05	2	230	2	20945348
Pubmed	Suppression of the lipopolysaccharide-induced expression of MARCKS-related protein (MRP) affects transmigration in activated RAW264.7 cells.	MARCKSL1 MARCKS	4.35e-05	2	230	2	19246034
Pubmed	GNAS A-1121G variant is associated with improved diastolic dysfunction in response to exercise training in heart failure patients.	ADRB1 GNAS	4.35e-05	2	230	2	23065660
Pubmed	Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice.	SHANK1 SHANK3	4.35e-05	2	230	2	33402706
Pubmed	ERK/p90(RSK)/14-3-3 signalling has an impact on expression of PEA3 Ets transcription factors via the transcriptional repressor capicúa.	ETV4 CIC	4.35e-05	2	230	2	21087211
Pubmed	Molecular analysis of 23 Pakistani families with autosomal recessive primary microcephaly using targeted next-generation sequencing.	ASPM WDR62	4.35e-05	2	230	2	27784895
Pubmed	DNA of neutrophil extracellular traps promote NF-κB-dependent autoimmunity via cGAS/TLR9 in chronic obstructive pulmonary disease.	CGAS TLR9	4.35e-05	2	230	2	38880789
Pubmed	Effects of human SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of acetaminophen and opioid drugs by the cytosolic sulfotransferase SULT1A3.	SULT1A3 SULT1A4	4.35e-05	2	230	2	29705271
Pubmed	A cell motility screen reveals role for MARCKS-related protein in adherens junction formation and tumorigenesis.	MARCKSL1 MARCKS	4.35e-05	2	230	2	19924305
Pubmed	Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.	FGFR4 GNAS	4.35e-05	2	230	2	18070145
Pubmed	MacMARCKS, a novel member of the MARCKS family of protein kinase C substrates.	MARCKSL1 MARCKS	4.35e-05	2	230	2	1516135
Pubmed	Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse.	ADRB1 GNAS	4.35e-05	2	230	2	10487769
Pubmed	[Genetic dependency of blood pressure and heart rate in patients with arterial hypertension and obesity].	ADRB1 GNAS	4.35e-05	2	230	2	25558679
Pubmed	Involvement of BREK, a serine/threonine kinase enriched in brain, in NGF signalling.	LMTK2 AATK	4.35e-05	2	230	2	15005709
Pubmed	Effects of polymorphisms in beta1-adrenoceptor and alpha-subunit of G protein on heart rate and blood pressure during exercise test. The Finnish Cardiovascular Study.	ADRB1 GNAS	4.35e-05	2	230	2	16210433
Pubmed	Human intestinal anion exchanger isoforms: expression, distribution, and membrane localization.	SLC4A3 SLC4A2	4.35e-05	2	230	2	11248201
Pubmed	Effect of 393T>C polymorphism of GNAS1 gene on dobutamine response in Chinese healthy subjects.	ADRB1 GNAS	4.35e-05	2	230	2	19542315
Pubmed	Heterotrimeric G protein Gαs subunit attenuates PLEKHG2, a Rho family-specific guanine nucleotide exchange factor, by direct interaction.	GNAS PLEKHG2	4.35e-05	2	230	2	28108261
Pubmed	Interaction of genes and metals in development.	BLOC1S6 EDARADD	4.35e-05	2	230	2	133823
Pubmed	Crystal structure of human catecholamine sulfotransferase.	SULT1A3 SULT1A4	4.35e-05	2	230	2	10543947
Pubmed	Phylogenomic approaches to common problems encountered in the analysis of low copy repeats: the sulfotransferase 1A gene family example.	SULT1A3 SULT1A4	4.35e-05	2	230	2	15752422
Pubmed	Tau-tubulin kinase 1 enhances prefibrillar tau aggregation and motor neuron degeneration in P301L FTDP-17 tau-mutant mice.	MAPT TTBK1	4.35e-05	2	230	2	20354135
Pubmed	Epigenome-wide association of myocardial infarction with DNA methylation sites at loci related to cardiovascular disease.	SMARCA4 ZFHX3	4.35e-05	2	230	2	28515798
Pubmed	Human liver thermolabile phenol sulfotransferase: cDNA cloning, expression and characterization.	SULT1A3 SULT1A4	4.35e-05	2	230	2	8117269
Pubmed	The regulation of MacMARCKS expression by integrin beta3.	MARCKSL1 MARCKS	4.35e-05	2	230	2	17292354
Pubmed	Acute inhibition of the CNS-specific kinase TTBK1 significantly lowers tau phosphorylation at several disease relevant sites.	MAPT TTBK1	4.35e-05	2	230	2	32255788
Pubmed	Axin forms a complex with MEKK1 and activates c-Jun NH(2)-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling.	MAP3K1 AXIN1	4.35e-05	2	230	2	10575011
Pubmed	MARCKS deficiency in mice leads to abnormal brain development and perinatal death.	MARCKSL1 MARCKS	4.35e-05	2	230	2	7862670
Pubmed	Impact of SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of phenylephrine and salbutamol by human SULT1A3 allozymes.	SULT1A3 SULT1A4	4.35e-05	2	230	2	31145702
Pubmed	cDNA cloning and tissue distribution of mRNAs for two proteins that are related to the band 3 Cl-/HCO3- exchanger.	SLC4A3 SLC4A2	4.35e-05	2	230	2	2294114
Pubmed	Analysis of BCL6-interacting proteins by tandem mass spectrometry.	WNK4 TNFRSF8 HELZ2 EHMT1 SMARCA4	5.77e-05	62	230	5	16147992
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MCM2 ZZEF1 ATP11B CASKIN2 HECW2 CASKIN1 ARAP1 MGRN1 LMTK2 SMG5 ARHGEF10L USP10 EHMT1	5.79e-05	529	230	13	14621295
Pubmed	Interplay of BAF and MLL4 promotes cell type-specific enhancer activation.	KMT2D SMARCA4 PRDM16	6.01e-05	12	230	3	33712604
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	AKAP8 PCNX3 SLC39A11 MARCKSL1 N4BP3 CCNK CIC PRR12 ZBTB7A WIZ CHD6 ZNF579 ESYT1 SAMD4B DDX51 HEXIM1 C6orf132 USP10 MICALL2 HELZ2 ANKRD11 EHMT1 ZFHX3 MARCKS	6.20e-05	1497	230	24	31527615
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	PPP1R13L CIC WIZ PTPRG CASKIN2 P3H1 SSH3 PPP1R37 PHLPP1 PDZD8 MICAL3 DMWD DEK FLVCR1 SHC1 LMTK2 NCKAP5L NHSL1 KMT2D	7.89e-05	1049	230	19	27880917
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	PPP1R13L ADD1 AXIN1 TXNL1 MICAL3 CAMSAP1 WDR62 NHSL1	8.18e-05	209	230	8	36779422
Pubmed	Identification of new ciliary signaling pathways in the brain and insights into neurological disorders.	MARCKSL1 TMEM132A RIPOR1 DMWD CACNA1E OGFRL1 SYT3 FLVCR1 SLC4A3 AATK MARCKS	8.99e-05	405	230	11	38187761
Pubmed	Mutation of ARHGAP9 in patients with coronary spastic angina.	ARHGEF17 ARHGAP25 PLEKHG2 ARHGEF10L	1.15e-04	38	230	4	19911011
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	ZNF831 ZZEF1 ARHGEF17 AFAP1L2 WIZ P3H1 HECW2 MCM3AP MAP3K9 CHD6 ZNF316 BRME1 GTF3C1 TM2D2 KCNG4	1.28e-04	736	230	15	29676528
Pubmed	Synaptic scaffolding proteins in rat brain. Ankyrin repeats of the multidomain Shank protein family interact with the cytoskeletal protein alpha-fodrin.	SHANK1 SHANK3	1.30e-04	3	230	2	11509555
Pubmed	Tau-tubulin kinase 1 (TTBK1), a neuron-specific tau kinase candidate, is involved in tau phosphorylation and aggregation.	MAPT TTBK1	1.30e-04	3	230	2	16923168
Pubmed	Translational neurobiology in Shank mutant mice--model systems for neuropsychiatric disorders.	SHANK1 SHANK3	1.30e-04	3	230	2	25917711
Pubmed	Targeted genetic dependency screen facilitates identification of actionable mutations in FGFR4, MAP3K9, and PAK5 in lung cancer.	MAP3K9 FGFR4	1.30e-04	3	230	2	23836671
Pubmed	Pendrin: an apical Cl-/OH-/HCO3- exchanger in the kidney cortex.	SLC4A3 SLC4A2	1.30e-04	3	230	2	11208611
Pubmed	The Trinity of cGAS, TLR9, and ALRs Guardians of the Cellular Galaxy Against Host-Derived Self-DNA.	CGAS TLR9	1.30e-04	3	230	2	33643304
Pubmed	Protein kinase A-anchoring protein AKAP95 interacts with MCM2, a regulator of DNA replication.	AKAP8 MCM2	1.30e-04	3	230	2	12740381
Pubmed	Direct binding of the beta1 adrenergic receptor to the cyclic AMP-dependent guanine nucleotide exchange factor CNrasGEF leads to Ras activation.	ADRB1 GNAS	1.30e-04	3	230	2	12391161
Pubmed	Glycogen synthase kinase 3 beta is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1).	MAP3K1 AXIN1	1.30e-04	3	230	2	12584189
Pubmed	Specific activation of PLEKHG2-induced serum response element-dependent gene transcription by four-and-a-half LIM domains (FHL) 1, but not FHL2 or FHL3.	GNAS PLEKHG2	1.30e-04	3	230	2	28489964
Pubmed	Structural and functional analysis of the apoptosis-associated tyrosine kinase (AATYK) family.	LMTK2 AATK	1.30e-04	3	230	2	17651901
Pubmed	Association between hypertension and the alpha-adducin, beta1-adrenoreceptor, and G-protein beta3 subunit genes in the Japanese population; the Suita study.	ADD1 ADRB1	1.30e-04	3	230	2	15055253
Pubmed	Reduction in parvalbumin expression not loss of the parvalbumin-expressing GABA interneuron subpopulation in genetic parvalbumin and shank mouse models of autism.	SHANK1 SHANK3	1.30e-04	3	230	2	26819149
Pubmed	CASK participates in alternative tripartite complexes in which Mint 1 competes for binding with caskin 1, a novel CASK-binding protein.	CASKIN2 CASKIN1	1.30e-04	3	230	2	12040031
Pubmed	Inactivation of Capicua drives cancer metastasis.	ETV4 CIC	1.30e-04	3	230	2	27869830
Pubmed	The Shank family of scaffold proteins.	SHANK1 SHANK3	1.30e-04	3	230	2	10806096
Pubmed	Polymorphisms of genes CYP2D6, ADRB1 and GNAS1 in pharmacokinetics and systemic effects of ophthalmic timolol. A pilot study.	ADRB1 GNAS	1.30e-04	3	230	2	16315032
Pubmed	Similarities and differences in the coupling of human beta1- and beta2-adrenoceptors to Gs(alpha) splice variants.	ADRB1 GNAS	1.30e-04	3	230	2	12106601
Pubmed	The in vivo regulation of heart rate in the murine sinoatrial node by stimulatory and inhibitory heterotrimeric G proteins.	GNAS HCN4	1.30e-04	3	230	2	23697798
Pubmed	Expression and function of bicarbonate/chloride exchangers in the preimplantation mouse embryo.	SLC4A3 SLC4A2	1.30e-04	3	230	2	7592657
Pubmed	USP8 Deubiquitinates SHANK3 to Control Synapse Density and SHANK3 Activity-Dependent Protein Levels.	SHANK1 SHANK3	1.30e-04	3	230	2	29735556
Pubmed	Dimerization choices control the ability of axin and dishevelled to activate c-Jun N-terminal kinase/stress-activated protein kinase.	MAP3K1 AXIN1	1.30e-04	3	230	2	10829020
Pubmed	Identification of two human brain aryl sulfotransferase cDNAs.	SULT1A3 SULT1A4	1.30e-04	3	230	2	8363592
Pubmed	Dendritic spine morphology and memory formation depend on postsynaptic Caskin proteins.	CASKIN2 CASKIN1	1.30e-04	3	230	2	31727973
Pubmed	A single amino acid, glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3.	SULT1A3 SULT1A4	1.30e-04	3	230	2	9855620
Pubmed	Modeling autism by SHANK gene mutations in mice.	SHANK1 SHANK3	1.30e-04	3	230	2	23583105
Pubmed	Structure of human estrogen and aryl sulfotransferase gene. Two mRNA species issued from a single gene.	SULT1A3 SULT1A4	1.30e-04	3	230	2	7961757
Pubmed	Grb2 interaction with MEK-kinase 1 is involved in regulation of Jun-kinase activities in response to epidermal growth factor.	MAP3K1 SHC1	1.30e-04	3	230	2	9733714
Pubmed	APLP1 and Rab5A interact with the II-III loop of the voltage-gated Ca-channel Ca(v)2.3 and modulate its internalization differently.	CACNA1E APLP1	1.30e-04	3	230	2	22178872
Pubmed	Dynamic Change of Shanks Gene mRNA Expression and DNA Methylation in Epileptic Rat Model and Human Patients.	SHANK1 SHANK3	1.30e-04	3	230	2	32564287
Pubmed	High-glucose induces tau hyperphosphorylation through activation of TLR9-P38MAPK pathway.	MAPT TLR9	1.30e-04	3	230	2	28803064
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	MCM2 ARHGAP30 PPP1R13L ARHGEF17 PGRMC1 PIK3R2 ARHGAP25 DEK ARAP1 PRR36 PLEKHG2 SYDE1 HEXIM1 ARHGEF10L WDR6 SMARCA4 MARCKS	1.41e-04	916	230	17	32203420
Pubmed	Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules.	PRAG1 AFAP1L2 PIK3R2 PHLPP1 SHC1	1.43e-04	75	230	5	15951569
Pubmed	The thiazide-sensitive Na(+)-Cl(-) cotransporter gene, C1784T, and adrenergic receptor-beta3 gene, T727C, may be gene polymorphisms susceptible to the antihypertensive effect of thiazide diuretics.	ADD1 ADRB1 WNK4	1.50e-04	16	230	3	15824464
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MAPT RBBP8NL ZBTB7A TNRC18 ATP11B PTPRG RIPOR1 MICAL3 CHD6 GNAS ARAP1 MGRN1 FLVCR1 SAMD4B HIVEP3 USP10 FOXP4 GTF3C1 MICAL2 SLC19A1 ANKRD11 EHMT1 ZFHX3	1.53e-04	1489	230	23	28611215
Pubmed	Complementary quantitative proteomics reveals that transcription factor AP-4 mediates E-box-dependent complex formation for transcriptional repression of HDM2.	ZBTB7A WIZ ZNF335 EHMT1 PRDM16	1.62e-04	77	230	5	19505873
Pubmed	High-throughput analyses of hnRNP H1 dissects its multi-functional aspect.	AKAP8 MAPT SLC39A11 CARD10 N4BP3 ZBTB7A PPP1R37 DMWD SEC14L1 PGGHG DDX51 FBXO46 SYDE1 HEXIM1 ARHGEF10L WDR6 ARHGAP45 RAB11FIP3	1.70e-04	1021	230	18	26760575
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	AKAP8 MCM2 CCNK PRR12 WIZ QARS1 DEK GOLGA2 WDR62 DDX51 HEXIM1 USP10 GTF3C1 JRK EHMT1 SMARCA4	1.82e-04	847	230	16	35850772
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	SNX21 PPP1R13L N4BP3 ADD1 MAP3K1 AXIN1 MCM3AP RIPOR1 GNAS DMWD DEK GOLGA2 SAMD4B SHC1 NCKAP5L AKT1S1 SYDE1 PRICKLE3	2.08e-04	1038	230	18	26673895
Pubmed	ER-export and ARFRP1/AP-1-dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication.	UNC5B MCM2 MARCKSL1 PGRMC1 ADD1 TXNL1 PDZD8 GNAS GOLGA2 MGRN1 CARMIL2 ESYT1 FLVCR1 SLC4A2 WDR6 SLC19A1 MARCKS	2.22e-04	952	230	17	38569033
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	PCNX3 MARCKSL1 ADD1 AFAP1L2 PTPRG CASKIN2 GNAS ESYT1 FLVCR1 MARCKS	2.27e-04	377	230	10	38117590
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	CIC PRR12 WIZ KMT2D SMARCA4	2.31e-04	83	230	5	28794006
Interaction	TOP3B interactions	VWA5B2 ZXDC RIN3 PCNX3 CARD10 DYSF ZZEF1 PRAG1 PGRMC1 REXO1 GADD45A CIC PRR12 TNRC18 WIZ PLEKHM2 CASKIN1 TMCC2 MCM3AP TMEM132A PDZD8 RIPOR1 MICAL3 GNAS ZNF579 CAMSAP1 DMWD QARS1 LTBP4 METTL27 ARAP1 RAD9A DPH2 B4GALNT4 ESYT1 SAMD4B ZNF316 SHC1 LMTK2 RAPGEF1 RHOT2 SMG5 FBXO46 ARHGEF10L C6orf132 HIVEP3 NHSL1 GAS2L1 USP10 KMT2D AATK MAP1S SLC45A3 ZNF335 HELZ2 ANKRD11 EHMT1 LTBP3 PRDM16 RAB11FIP3	2.02e-20	1470	213	60	int:TOP3B
Interaction	ZNF683 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	3.04e-08	10	213	5	int:ZNF683
Interaction	CELF4 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	5.52e-08	11	213	5	int:CELF4
Interaction	TPRX1 interactions	PRR20C PRR20D PRR20B PRR20E GOLGA2 PRR20A	6.18e-08	21	213	6	int:TPRX1
Interaction	TLX3 interactions	CIC PRR12 PRR20C PRR20D PRR20B WIZ PRR20E CHD6 DEK METTL27 PRR20A TBX18 FOXP4 KMT2D EHMT1 ZFHX3	8.90e-08	291	213	16	int:TLX3
Interaction	BEND2 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	9.38e-08	12	213	5	int:BEND2
Interaction	PTTG2 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	2.33e-07	14	213	5	int:PTTG2
Interaction	MBNL3 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	5.00e-07	16	213	5	int:MBNL3
Interaction	PITX1 interactions	SPAG8 CIC PRR20C PRR20D PRR20B PRR20E METTL27 GOLGA2 PRR20A WDR6	1.00e-06	127	213	10	int:PITX1
Interaction	ZNF385C interactions	PRR20C PRR20D PRR20B PRR20E ZNF579 PRR20A	1.13e-06	33	213	6	int:ZNF385C
Interaction	PRR34 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	2.23e-06	21	213	5	int:PRR34
Interaction	SOX7 interactions	RREB1 PRR12 TNRC18 WIZ FOXP4 KMT2D SMARCA4 PRDM16	2.49e-06	82	213	8	int:SOX7
Interaction	PRR35 interactions	CARD10 SPAG8 N4BP3 PRR20C PRR20D PRR20B PRR20E PRR20A	2.73e-06	83	213	8	int:PRR35
Interaction	YWHAG interactions	CDK18 AARS1 AKAP8 MAPT MCM2 N4BP3 ARHGEF17 PRAG1 CIC MAP3K1 TTBK1 CASKIN2 MAP3K9 GNAS CAMSAP1 DMWD WDR62 CARMIL2 ESYT1 SAMD4B SHC1 LMTK2 PLEKHG2 NCKAP5L AKT1S1 SHANK3 SYDE1 HEXIM1 C6orf132 NHSL1 PRICKLE3 ANKRD11	2.91e-06	1248	213	32	int:YWHAG
Interaction	TBX6 interactions	PRR20C PRR20D PRR20B PRR20E METTL27 PRR20A	4.29e-06	41	213	6	int:TBX6
Interaction	NCK2 interactions	RBBP8NL AXIN1 PRR20C PRR20D PRR20B CASKIN2 PRR20E SSH3 FGFR4 SKAP2 ARAP1 PRR20A NHSL1	4.61e-06	262	213	13	int:NCK2
Interaction	RHOQ interactions	UNC5B MARCKSL1 ADD1 PTPRG CASKIN2 PIK3R2 PDZD8 MICAL3 GNAS ESYT1 FLVCR1 RAPGEF1 SYDE1 SLC4A2 WDR6 SLC19A1 MARCKS	5.05e-06	442	213	17	int:RHOQ
Interaction	BICRAL interactions	PRR20C PRR20D PRR20B PRR20E PRR20A SMARCA4	5.72e-06	43	213	6	int:BICRAL
Interaction	VSX1 interactions	RREB1 CIC WIZ CHD6 FOXP4 EHMT1 ZFHX3	6.13e-06	66	213	7	int:VSX1
Interaction	SMAP1 interactions	PRR20C PRR20D PRR20B PRR20E FGFR4 NPW PRR20A	6.78e-06	67	213	7	int:SMAP1
Interaction	C3orf36 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	6.91e-06	26	213	5	int:C3orf36
Interaction	RAC1 interactions	AARS1 MAPT UNC5B MARCKSL1 ADD1 PTPRG CASKIN2 PIK3R2 MCM3AP PDZD8 MICAL3 GNAS LTBP4 ARAP1 CARMIL2 ESYT1 FLVCR1 RNF149 RAPGEF1 PLEKHG2 NCKAP5L SHANK3 SYDE1 SLC4A2 WDR6 SLC19A1 LTBP3 MARCKS	7.91e-06	1063	213	28	int:RAC1
Interaction	SP4 interactions	ZBTB7A PRR20C PRR20D PRR20B PRR20E PRR20A	8.55e-06	46	213	6	int:SP4
Interaction	FEV interactions	RREB1 CIC PRR12 ZBTB7A WIZ CHD6 FOXP4 KMT2D GTF3C1 EHMT1 ZFHX3	1.11e-05	203	213	11	int:FEV
Interaction	TRIM35 interactions	VWA5B2 PRR20C PRR20D PRR20B PRR20E SSH3 QARS1 PRR20A	1.37e-05	103	213	8	int:TRIM35
Interaction	OXER1 interactions	CCNK PRR20C PRR20D PRR20B PRR20E PRR20A	1.40e-05	50	213	6	int:OXER1
Interaction	CDK1 interactions	CDK18 ASXL1 MAPT MCM2 PGRMC1 CCNK GADD45A CIC ADD1 UBE2A FGFR4 GOLGA2 RAD9A RNF149 PLEKHG2 HEXIM1 PITPNM1 AATK MARCKS	1.75e-05	590	213	19	int:CDK1
Interaction	STX5 interactions	GPR152 PGRMC1 PDZD8 GOLGA2 ESYT1 RNF149 APLP1 RHOT2 KASH5 MICALL2 PLPP4 MARCKS	1.90e-05	256	213	12	int:STX5
Interaction	SH3RF1 interactions	PRR20C PRR20D PRR20B PRR20E MAP3K9 FGFR4 WDR62 PRR20A	1.94e-05	108	213	8	int:SH3RF1
Interaction	TLX2 interactions	CIC PRR12 WIZ CHD6 FOXP4 KMT2D GTF3C1 EHMT1 ZFHX3	2.06e-05	142	213	9	int:TLX2
Interaction	KDM1A interactions	MAPT MCM2 CARD10 RREB1 RBBP8NL CIC PRR12 TXNL1 WIZ NR1H2 CHD6 CAMSAP1 METTL27 GOLGA2 WDR62 SHC1 TLR9 KMT2D GTF3C1 KASH5 WDR6 JRK EHMT1 ZFHX3 ECE2	2.19e-05	941	213	25	int:KDM1A
Interaction	YWHAB interactions	CDK18 RIN3 AKAP8 MAPT MCM2 N4BP3 ARHGEF17 CIC PIK3R2 MAP3K9 USP4 FGFR4 CAMSAP1 DMWD WDR62 CARMIL2 ESYT1 SAMD4B NCKAP5L AKT1S1 SHANK3 SYDE1 C6orf132 NHSL1 PRICKLE3 MARCKS	2.72e-05	1014	213	26	int:YWHAB
Interaction	ZBTB32 interactions	SPAG8 PRR20C PRR20D PRR20B PRR20E PRR20A	3.33e-05	58	213	6	int:ZBTB32
Interaction	GSC interactions	RREB1 PRR12 TNRC18 FOXP4 KMT2D ZFHX3 PRDM16	3.81e-05	87	213	7	int:GSC
Interaction	YWHAH interactions	CDK18 RIN3 AKAP8 MAPT MCM2 N4BP3 ARHGEF17 PRAG1 CIC CASKIN2 MAP3K9 USP4 CAMSAP1 DMWD WDR62 CARMIL2 ESYT1 SAMD4B LMTK2 PLEKHG2 NCKAP5L AKT1S1 SYDE1 C6orf132 NHSL1 PRICKLE3 ANKRD11	4.14e-05	1102	213	27	int:YWHAH
Interaction	ELK3 interactions	ASXL1 RREB1 CIC WIZ CHD6 FOXP4 EHMT1 PRDM16	4.16e-05	120	213	8	int:ELK3
Interaction	HLX interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	4.16e-05	37	213	5	int:HLX
Interaction	ZCCHC14 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	4.16e-05	37	213	5	int:ZCCHC14
Interaction	GJA1 interactions	AARS1 PCNX3 UNC5B THSD1 UBE2A PTPRG CASKIN2 PIK3R2 PDZD8 GOLGA2 ESYT1 FLVCR1 CGAS LMTK2 SLC4A2 WDR6 SLC19A1 PLPP4	5.06e-05	583	213	18	int:GJA1
Interaction	GATA2 interactions	CIC PRR12 WIZ CHD6 GOLGA2 PRR20A KMT2D EHMT1 SMARCA4 ZFHX3	5.30e-05	199	213	10	int:GATA2
Interaction	ABI2 interactions	MAPT EPS8L1 BLOC1S6 PRR20C PRR20D PRR20B CASKIN2 PRR20E FGFR4 PRR20A SHANK3 NHSL1	5.60e-05	286	213	12	int:ABI2
Interaction	CAPZA2 interactions	ASXL1 RIN3 MAPT MCM2 CARD10 N4BP3 ARHGEF17 ADD1 SSH3 MICAL3 ARAP1 CARMIL2 FBXO46 SHANK3 GAS2L1	5.65e-05	430	213	15	int:CAPZA2
Interaction	RBM23 interactions	PRR20C PRR20D PRR20B PRR20E ZNF579 PRR20A GTF3C1	6.27e-05	94	213	7	int:RBM23
Interaction	LASP1 interactions	RIN3 MAPT SPAG8 PRR20C PRR20D PRR20B PRR20E USP4 FGFR4 GOLGA2 PRR20A	6.74e-05	247	213	11	int:LASP1
Interaction	FAM222B interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	7.79e-05	42	213	5	int:FAM222B
Interaction	CCNK interactions	CDK18 CCNK PRR20C PRR20D PRR20B PRR20E HECW2 PRR20A	8.19e-05	132	213	8	int:CCNK
Interaction	SAMD11 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	8.74e-05	43	213	5	int:SAMD11
Interaction	EGR2 interactions	RREB1 PRR12 TNRC18 WIZ GOLGA2 FOXP4 KMT2D ZFHX3 PRDM16	8.82e-05	171	213	9	int:EGR2
Interaction	TBX3 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A USP10	8.94e-05	69	213	6	int:TBX3
Interaction	PHF1 interactions	SPAG8 RBBP8NL DYSF PRR20C PRR20D PRR20B PRR20E DEK PRR20A	9.23e-05	172	213	9	int:PHF1
Interaction	RAC3 interactions	MAPT UNC5B ADD1 CASKIN2 PIK3R2 PDZD8 MICAL3 GNAS ESYT1 FLVCR1 CGAS RAPGEF1 SYDE1 SLC4A2 WDR6 SLC19A1 ANKRD11 MARCKS	1.08e-04	619	213	18	int:RAC3
Interaction	CDRT15P3 interactions	VWA5B2 MAP1S WDR6 CDRT15P3	1.09e-04	24	213	4	int:CDRT15P3
Interaction	RHOU interactions	UNC5B MARCKSL1 ADD1 TXNL1 PTPRG CASKIN2 PIK3R2 INSM2 NR1H2 GNAS ESYT1 FLVCR1 SLC4A2 WDR6 SLC19A1 MARCKS	1.11e-04	510	213	16	int:RHOU
Interaction	RHOXF2 interactions	CCNK PRR20C PRR20D PRR20B PRR20E TMCC2 PRR20A	1.19e-04	104	213	7	int:RHOXF2
Interaction	MAPRE1 interactions	MAPT PPP1R13L ADD1 AXIN1 TTBK1 USP4 FGFR4 CAMSAP1 QARS1 WDR62 CGAS NCKAP5L GAS2L1 USP10 MAP1S RAB11FIP3	1.21e-04	514	213	16	int:MAPRE1
Interaction	C11orf52 interactions	UNC5B ADD1 PTPRG CASKIN2 PIK3R2 MICAL3 ESYT1 FLVCR1 SLC4A2 WDR6 SLC19A1 MARCKS	1.24e-04	311	213	12	int:C11orf52
Interaction	VPS37C interactions	SPAG8 PRR20C PRR20D PRR20B PRR20E METTL27 GOLGA2 PRR20A	1.30e-04	141	213	8	int:VPS37C
Interaction	RAB35 interactions	UNC5B PGRMC1 ADD1 PTPRG CASKIN2 PIK3R2 PPP1R37 PDZD8 MICAL3 ESYT1 FLVCR1 RNF149 HEXIM1 SLC4A2 WDR6 SLC19A1 MARCKS	1.33e-04	573	213	17	int:RAB35
Interaction	KRTAP19-1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	1.35e-04	47	213	5	int:KRTAP19-1
Interaction	PAX6 interactions	PDE4C MARCKSL1 RREB1 CIC PRR12 WIZ CHD6 SHANK3 KMT2D GTF3C1 EHMT1 SMARCA4 ZFHX3	1.48e-04	366	213	13	int:PAX6
Interaction	H2BC21 interactions	RIN3 MCM2 ARHGAP30 RREB1 GADD45A PRR12 UBE2A WIZ ATP11B USP42 P3H1 MAP3K9 DEK CACNA1E CGAS SMG5 HEXIM1 EHMT1 SMARCA4	1.58e-04	696	213	19	int:H2BC21
Interaction	CRKL interactions	RIN3 MCM2 PRAG1 PIK3R2 USP4 FGFR4 LTBP4 SHC1 RAPGEF1 SHANK3	1.58e-04	227	213	10	int:CRKL
Interaction	CDC37 interactions	CDK18 MAPT CARD10 MAP3K1 PRR20C PRR20D PRR20B PRR20E PHLPP1 PDZD8 FGFR4 DMWD GOLGA2 PRR20A HEXIM1 AATK WDR6 JRK	1.80e-04	645	213	18	int:CDC37
Interaction	NOTCH3 interactions	PRR20C PRR20D PRR20B PRR20E RNF149 PRR20A SHANK3	2.00e-04	113	213	7	int:NOTCH3
Interaction	DVL3 interactions	MAPT CCNK AXIN1 PRR20C PRR20D PRR20B PRR20E PHLPP1 FAM13C PRR20A SHANK3	2.03e-04	280	213	11	int:DVL3
Interaction	NES interactions	ADD1 SLC35G1 TMEM132A PHLPP1 GOLGA2 CGAS SHANK3 MICALL2	2.18e-04	152	213	8	int:NES
Interaction	PFKP interactions	MAPT MCM2 PGRMC1 CIC ZBTB7A USP4 FGFR4 DMWD RNF149 AATK PRDM16	2.30e-04	284	213	11	int:PFKP
Interaction	PIN1 interactions	MAPT GPR152 RBBP8NL CCNK AXIN1 SSC5D UBE2A WIZ QARS1 GOLGA2 APLP1 PLEKHG2 MAP1S	2.31e-04	383	213	13	int:PIN1
Interaction	STX7 interactions	MAPT UNC5B MARCKSL1 EPS8L1 ADD1 CASKIN2 PPP1R37 PDZD8 MICAL3 GOLGA2 ESYT1 FLVCR1 RNF149 LMTK2 SLC4A2 WDR6 SLC19A1 MARCKS	2.34e-04	659	213	18	int:STX7
Interaction	DPP8 interactions	AARS1 EPS8L1 KRBA1 P3H1 DMWD	2.39e-04	53	213	5	int:DPP8
Interaction	RBPMS2 interactions	PRR20C PRR20D PRR20B PRR20E PPP1R37 PRR20A	2.49e-04	83	213	6	int:RBPMS2
Interaction	LAMTOR1 interactions	UNC5B ADD1 AXIN1 BLOC1S6 PTPRG PLEKHM2 CASKIN2 PIK3R2 TMEM132A PPP1R37 PDZD8 GNAS FLVCR1 CGAS LMTK2 SLC4A2 WDR6 SLC19A1 MARCKS	2.51e-04	722	213	19	int:LAMTOR1
Interaction	RCOR1 interactions	RREB1 CIC TXNL1 CHD6 CAMSAP1 GOLGA2 WDR62 NCKAP5L KMT2D WDR6 EHMT1 SMARCA4 ZFHX3 PRDM16 ECE2	2.58e-04	494	213	15	int:RCOR1
Interaction	BHLHE40 interactions	CCNK PRR20C PRR20D PRR20B PRR20E PRR20A ZFHX3	2.75e-04	119	213	7	int:BHLHE40
Interaction	SNAP47 interactions	BLOC1S6 PDZD8 GOLGA2 ESYT1 RHOT2 KASH5 TNFRSF8 MARCKS	2.83e-04	158	213	8	int:SNAP47
Interaction	RIPPLY1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	2.85e-04	55	213	5	int:RIPPLY1
Interaction	CDK4 interactions	RIN3 MCM2 PGRMC1 ASPM FGFR4 QARS1 OGFRL1 APLP1 HEXIM1 ZNF335 MARCKS	2.91e-04	292	213	11	int:CDK4
Interaction	RND1 interactions	UNC5B TXNL1 PTPRG PIK3R2 GNAS ESYT1 FLVCR1 WDR6 SLC19A1 MARCKS	3.01e-04	246	213	10	int:RND1
Interaction	DMRT3 interactions	SPAG8 PRR20C PRR20D PRR20B PRR20E PRR20A	3.22e-04	87	213	6	int:DMRT3
Interaction	PRSS3 interactions	RIN3 MCM2 UBE2A SHC1 PRDM16	3.37e-04	57	213	5	int:PRSS3
Interaction	PAX7 interactions	RREB1 CIC PRR12 CHD6 FOXP4 KMT2D ZFHX3	3.53e-04	124	213	7	int:PAX7
Interaction	IRF8 interactions	CIC PRR12 USP4 KMT2D EHMT1	3.66e-04	58	213	5	int:IRF8
Interaction	PRR20B interactions	CCNK PRR20C PRR20D PRR20B PRR20E PRR20A	3.87e-04	90	213	6	int:PRR20B
Interaction	PRR20C interactions	CCNK PRR20C PRR20D PRR20B PRR20E PRR20A	3.87e-04	90	213	6	int:PRR20C
Interaction	PRR20D interactions	CCNK PRR20C PRR20D PRR20B PRR20E PRR20A	3.87e-04	90	213	6	int:PRR20D
Interaction	FAM9A interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	3.96e-04	59	213	5	int:FAM9A
Interaction	SLC25A11 interactions	MAPT MCM2 CIC SHC1 LMTK2 FBXO46 SHANK3 HEXIM1 AATK PRDM16	4.00e-04	255	213	10	int:SLC25A11
Interaction	RUVBL1 interactions	RIN3 AKAP8 MAPT MCM2 CIC ZBTB7A PHLPP1 GNAS RNF149 SHC1 FBXO46 SHANK3 HEXIM1 ARHGEF10L USP10 MARCKS	4.26e-04	575	213	16	int:RUVBL1
Interaction	CABP2 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	4.63e-04	61	213	5	int:CABP2
Interaction	XAGE2 interactions	WIZ FOXP4 EHMT1	4.82e-04	15	213	3	int:XAGE2
Interaction	ARF6 interactions	UNC5B MARCKSL1 PGRMC1 ADD1 PTPRG PIK3R2 PDZD8 ESYT1 FLVCR1 DGKD SLC4A2 WDR6 SLC19A1 ZFHX3 MARCKS RAB11FIP3	5.04e-04	584	213	16	int:ARF6
Interaction	SOX17 interactions	MCM2 CIC PRR12 WIZ FOXP4 KMT2D	5.17e-04	95	213	6	int:SOX17
Cytoband	Ensembl 112 genes in cytogenetic band chr7q11	SPDYE11 SPDYE13 SPDYE15 SPDYE21 SPDYE5 METTL27 SPDYE14 SPDYE17 SPDYE10 SPDYE9 SPDYE18 SPDYE12 SPDYE8	1.70e-09	271	233	13	chr7q11
Cytoband	13q21.1	PRR20C PRR20D PRR20B PRR20E PRR20A	4.02e-09	13	233	5	13q21.1
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	TTC9B EPS8L1 PPP1R13L CIC PRR12 SSC5D PPP1R37 RNF225 NR1H2 ZNF579 DMWD LTBP4 WDR62 SHANK1 ERFL ZNF473 SYT3 SAMD4B APLP1 PLEKHG2 FBXO46 AKT1S1 KASH5	5.52e-08	1192	233	23	chr19q13
Cytoband	7q11.23	SPDYE5 METTL27 SPDYE14 SPDYE10 SPDYE9 SPDYE18 SPDYE8	6.91e-07	97	233	7	7q11.23
Cytoband	9q34.3	CEL CAMSAP1 RAPGEF1 DNLZ EHMT1	2.15e-04	106	233	5	9q34.3
Cytoband	19q13.33	PRR12 ZNF473 SYT3 AKT1S1 KASH5	2.15e-04	106	233	5	19q13.33
Cytoband	16p13.3	KREMEN2 AXIN1 CASKIN1 NPW MGRN1 RHOT2 RAB11FIP3	2.68e-04	244	233	7	16p13.3
Cytoband	Ensembl 112 genes in cytogenetic band chr13q21	PRR20C PRR20D PRR20B PRR20E PRR20A	3.41e-04	117	233	5	chr13q21
Cytoband	10q26.12	PDZD8 PLPP4	5.30e-04	7	233	2	10q26.12
Cytoband	Ensembl 112 genes in cytogenetic band chr11q13	PCNX3 GPR152 ARHGEF17 SSH3 ARAP1 RAD9A PITPNM1 ZFTA LTBP3	5.70e-04	454	233	9	chr11q13
Cytoband	19q13.3	NR1H2 DMWD SHANK1 FBXO46	8.29e-04	82	233	4	19q13.3
Cytoband	Ensembl 112 genes in cytogenetic band chr19p13	PDE4C AKAP8 REXO1 ZBTB7A WIZ PIK3R2 PRR36 BRME1 SYDE1 MAP1S SMARCA4 ARHGAP45	8.52e-04	797	233	12	chr19p13
Cytoband	Ensembl 112 genes in cytogenetic band chr9q34	CEL CAMSAP1 GOLGA2 RAPGEF1 DNLZ EHMT1 PRRT1B	1.45e-03	325	233	7	chr9q34
Cytoband	19q13.2	TTC9B CIC ERFL SAMD4B PLEKHG2	1.56e-03	164	233	5	19q13.2
Cytoband	Ensembl 112 genes in cytogenetic band chr16p13	KREMEN2 AXIN1 CASKIN1 NPW MGRN1 RHOT2 PERCC1 RAB11FIP3	1.61e-03	426	233	8	chr16p13
Cytoband	7p22.1	TNRC18 USP42 ZNF316	1.77e-03	47	233	3	7p22.1
GeneFamily	Sterile alpha motif domain containing	CASKIN2 CASKIN1 ARAP1 SHANK1 SAMD4B DGKD SHANK3	9.28e-06	88	152	7	760
GeneFamily	Ankyrin repeat domain containing	ANKRD63 PPP1R13L CASKIN2 CASKIN1 ARAP1 ANKRD30BL SHANK1 SHANK3 ANKRD11 EHMT1	3.91e-05	242	152	10	403
GeneFamily	Speedy/RINGO cell cycle regulator family	SPDYE5 SPDYE9 SPDYE8	1.21e-04	12	152	3	756
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	AFAP1L2 PLEKHM2 PHLPP1 ARHGAP25 SKAP2 ARAP1 DGKD PLEKHG2	3.58e-04	206	152	8	682
GeneFamily	Latent transforming growth factor beta binding proteins	LTBP4 LTBP3	4.17e-04	4	152	2	628
GeneFamily	LIM domain containing	MICAL3 MICALL2 PRICKLE3 MICAL2	1.53e-03	59	152	4	1218
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	KMT2D EHMT1 PRDM16	2.88e-03	34	152	3	487
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN	ZXDC PDE4C DYSF ZZEF1 REXO1 AXIN1 KRBA1 SULT1A3 PLEKHM2 PIK3R2 SSH3 MCM3AP RIPOR1 USP4 LTBP4 SEC14L1 RAPGEF1 RHOT2 SMG5 PITPNM1 SULT1A4 WDR6 HELZ2 ANKRD11 SMARCA4 ZFHX3	3.49e-08	905	216	26	M40865
Coexpression	PRC2_EED_DN.V1_DN	CDK18 MCM2 ARHGEF17 WIZ CASKIN2 RAPGEF1 APLP1 HIVEP3 MICALL2 PRICKLE3 TNS4	6.46e-07	193	216	11	M2734
Coexpression	GSE3982_MAST_CELL_VS_NKCELL_DN	ASXL1 UNC5B ETV4 PPP1R13L ARAP1 PGGHG APLP1 MAP1S MICAL2 ANKRD11	6.46e-06	199	216	10	M5452
Coexpression	FOSTER_KDM1A_TARGETS_DN	KRBA1 ATP11B PIK3R2 RNF225 ZNF579 QARS1 SEC14L1 SHC1 APLP1 LTBP3	7.37e-06	202	216	10	M2514
Coexpression	FOSTER_KDM1A_TARGETS_DN	KRBA1 ATP11B PIK3R2 RNF225 ZNF579 QARS1 SEC14L1 SHC1 APLP1 LTBP3	8.39e-06	205	216	10	MM957
Coexpression	LIM_MAMMARY_STEM_CELL_UP	SERPINF1 CARD10 THSD1 STAC2 P3H1 EDARADD ARHGAP25 DMWD LTBP4 RAPGEF1 SLC4A3 SYDE1 RFLNB MICAL2 TNS4	1.15e-05	479	216	15	M2573
Coexpression	GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_UP	UNC5B HOXA7 TMCC2 ALPK3 DPH2 SCARF1 AATK PRDM16	1.21e-05	129	216	8	M464
Coexpression	LIM_MAMMARY_STEM_CELL_UP	SERPINF1 CARD10 THSD1 STAC2 P3H1 EDARADD ARHGAP25 DMWD LTBP4 RAPGEF1 SLC4A3 SYDE1 RFLNB MICAL2 TNS4	1.27e-05	483	216	15	MM1082
Coexpression	ZHONG_PFC_C3_ASTROCYTE	TSPOAP1 TTC9B CIC MCM3AP MAP3K9 PDZD4 MGRN1 CACNA1E B4GALNT4 ZNF316 SLC4A3 RFLNB ZFTA	2.28e-05	389	216	13	M39102
Coexpression	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3	CDK18 RIN3 UNC5B KREMEN2 CARD10 ANKRD63 N4BP3 DYSF ARHGEF17 STAC2 AFAP1L2 EDARADD ASPM GNAS SKAP2 WNK4 HCN4 CGAS BCAN TBX18 FOXP4 PLPP4 PRDM16	2.95e-05	1074	216	23	M1941
Coexpression	GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_UP	MAPT KREMEN2 NPAS3 MICAL3 PGGHG KMT2D CLEC14A HELZ2 MARCKS	3.40e-05	193	216	9	M9233
Coexpression	GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	TXNL1 UBE2A WIZ RAPGEF1 FBXO46 ARHGEF10L HIVEP3 MICALL2 ANKRD11	3.68e-05	195	216	9	M3145
Coexpression	GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP	ARHGAP30 CIC MAP3K1 TNRC18 PDZD8 GNAS PGGHG KMT2D MICAL2	4.15e-05	198	216	9	M7948
Coexpression	GSE18893_TCONV_VS_TREG_24H_CULTURE_DN	RIN3 GADD45A RNF157 EDARADD ARHGAP25 DMWD HIVEP3 IL21R ZFTA	4.48e-05	200	216	9	M7289
Coexpression	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	ETV4 USP4 GNAS BRME1 GTF3C1	4.66e-05	48	216	5	M18328
Coexpression	BUSSLINGER_DUODENAL_TUFT_CELLS	MARCKSL1 FGFR4 SKAP2 ANKRD30BL B4GALNT4 ZFHX3	5.67e-05	81	216	6	M40033
Coexpression	ZHONG_PFC_C3_MICROGLIA	TSPOAP1 MAPT TTC9B MARCKSL1 RNF157 PIK3R2 TMEM132A DMWD CACNA1E B4GALNT4 SYT3 SAMD4B DDX51 ZFTA	5.86e-05	488	216	14	M39104
Coexpression	SCHLOSSER_SERUM_RESPONSE_UP	PDE4C MAPT ZBTB7A PLEKHM2 USP4 ARHGAP25 PITPNM1	8.63e-05	126	216	7	M16381
Coexpression	MARTENS_BOUND_BY_PML_RARA_FUSION	TSPOAP1 ARHGAP30 ZZEF1 TMCC2 ARAP1 RNF149 RAPGEF1 FBXO46 HIVEP3 ANKRD11 LTBP3 ARHGAP45 RAB11FIP3	1.15e-04	456	216	13	M2094
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	ARHGAP30 REXO1 CIC DMWD ZNF473 ZNF316 SMG5 NCKAP5L FBXO46 KMT2D SMARCA4	1.23e-04	338	216	11	M17094
CoexpressionAtlas	gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K3	RIN3 CARD10 THSD1 N4BP3 DYSF HOXA7 STAC2 ARHGAP25 SKAP2 SCARF1	1.63e-05	185	210	10	gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K3
ToppCell	Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	UNC5B MARCKSL1 THSD1 N4BP3 DYSF ADRB1 HECW2 TMEM132A SEC14L1 SHANK3 RFLNB CLEC14A	3.08e-10	193	224	12	ff6e6b825d6c88148216c601580be3c28851ab5c
ToppCell	wk_15-18-Endothelial-Blood_vessel_endothelial-Late_cap\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CARD10 THSD1 N4BP3 ADRB1 SULT1A3 CASKIN2 HECW2 SHANK3 SCARF1 SULT1A4 RFLNB CLEC14A	3.46e-10	195	224	12	dfc5da514fb34a2c318a5c4c61f44049fa43960e
ToppCell	wk_20-22-Endothelial\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CARD10 THSD1 N4BP3 DYSF SULT1A3 CASKIN2 HECW2 SHANK3 SCARF1 SULT1A4 CLEC14A	5.89e-09	199	224	11	07be9509a8ec9c9a7d721912d77c20e841f49808
ToppCell	wk_08-11-Endothelial-Blood_vessel_endothelial-Late_cap\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	THSD1 N4BP3 DYSF ADRB1 CASKIN2 HECW2 SHANK3 SCARF1 RFLNB CLEC14A	3.27e-08	183	224	10	3e69cc605f166a1f04e3d077935f7cfd806f1ffd
ToppCell	356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	UNC5B THSD1 N4BP3 DYSF ADRB1 CASKIN2 HECW2 TMEM132A SHANK3 CLEC14A	3.81e-08	186	224	10	f0b78c7ee20279970ea8961bf59acb5262f2dce5
ToppCell	356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|356C / Donor, Lineage, Cell class and subclass (all cells)	UNC5B THSD1 N4BP3 DYSF ADRB1 CASKIN2 HECW2 TMEM132A SHANK3 CLEC14A	3.81e-08	186	224	10	2b3c814a7dee8286ea113c63dc3de5daf0257d37
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	THSD1 N4BP3 DYSF PTPRG CASKIN2 HECW2 SEC14L1 FAM13C SHANK3 CLEC14A	4.21e-08	188	224	10	117dc80fa940e6aa1b0187a43fdde33f3fcb578f
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD1 ADRB1 PTPRG HECW2 TMCC2 RIPOR1 SEC14L1 SHANK3 CLEC14A MICAL2	5.66e-08	194	224	10	f159ef8541d75a4e98468947f231bb463bec922c
ToppCell	facs-Lung-nan-3m-Endothelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC5B THSD1 ADRB1 PTPRG HECW2 RIPOR1 SHANK3 SLC45A3 CLEC14A MICAL2	5.95e-08	195	224	10	7f9b7f15006610ad591063d90e90367bd6083c7f
ToppCell	15-Distal-Endothelial\|Distal / Age, Tissue, Lineage and Cell class	CARD10 THSD1 N4BP3 DYSF ADRB1 HECW2 SEC14L1 SCARF1 RFLNB CLEC14A	6.24e-08	196	224	10	03245aca5cb97fd5c3f8a986efff7131ccd40e34
ToppCell	15-Distal-Endothelial-Endothelial\|Distal / Age, Tissue, Lineage and Cell class	CARD10 THSD1 N4BP3 DYSF ADRB1 HECW2 SEC14L1 SCARF1 RFLNB CLEC14A	6.24e-08	196	224	10	fda2dd3895bf6ae39fcce2050e4878750f5f5b71
ToppCell	Fetal_29-31_weeks-Endothelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	UNC5B CARD10 THSD1 N4BP3 DYSF CASKIN2 HECW2 SEC14L1 SHANK3 CLEC14A	6.24e-08	196	224	10	3981f6c7487598f4f7ce4650ac0ac5bd41481d66
ToppCell	wk_15-18-Endothelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CARD10 THSD1 N4BP3 DYSF SULT1A3 HECW2 SHANK3 SCARF1 SULT1A4 CLEC14A	6.86e-08	198	224	10	dcf453e22dba90c0ae349fa6c3d4c20758bb95af
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	STAC2 MAP3K9 PDZD4 SHANK1 B4GALNT4 RNF149 LMTK2 SHANK3 SKOR1	1.81e-07	167	224	9	9efb9511a211d0824bb97f82c1a5860c43d2138f
ToppCell	Cerebellum-Neuronal-Inhibitory\|Cerebellum / BrainAtlas - Mouse McCarroll V32	STAC2 MAP3K9 PDZD4 SHANK1 B4GALNT4 RNF149 LMTK2 SHANK3 SKOR1	1.81e-07	167	224	9	904c613aac3f9919a432b110bb1dcc832b5aec0a
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma\|TCGA-Colorectal / Sample_Type by Project: Shred V9	ASXL1 ETV4 FGFR4 ZNF316 SMG5 C6orf132 FOXP4 PRICKLE3 ZNF335	3.42e-07	180	224	9	c3d1521ac90f2e3fc31158e6e61907e05c37af39
ToppCell	wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	TSPOAP1 STAC2 PHLPP1 DDX51 NHSL1 KMT2D PRICKLE3 ZNF335 RAB11FIP3	4.30e-07	185	224	9	636505a3d96f75d951ab42bcf8af6ae07abc732d
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UNC5B MARCKSL1 THSD1 DYSF HECW2 SEC14L1 SHANK3 RFLNB CLEC14A	4.71e-07	187	224	9	0ef82111b9049cc7ee78d64d240e1f10ab14d6b6
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma\|TCGA-Kidney / Sample_Type by Project: Shred V9	CDK18 UNC5B DYSF KRBA1 HECW2 ARHGAP25 PLEKHG2 RFLNB CLEC14A	4.93e-07	188	224	9	e711c7a46d7cfa030ca2982eacc1dae5af5788dd
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UNC5B THSD1 N4BP3 DYSF CASKIN2 HECW2 SHANK3 RFLNB CLEC14A	5.15e-07	189	224	9	db09d591b885ce2bc9e353f08b6694e2192582e1
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC5B THSD1 DYSF ADRB1 CASKIN2 HECW2 RIPOR1 SHANK3 CLEC14A	5.38e-07	190	224	9	106ea0bb7b99c697ffc5443d72343df2484250c7
ToppCell	5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KREMEN2 MARCKSL1 AFAP1L2 CHD6 FGFR4 B4GALNT4 HEXIM1 ARHGEF10L ZFHX3	5.63e-07	191	224	9	54f07e4de61735051498846afb44b1798bed8144
ToppCell	3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UNC5B THSD1 N4BP3 DYSF HECW2 SEC14L1 SHANK3 SCARF1 CLEC14A	5.88e-07	192	224	9	1f35efb0765e05f7f9c881849953bef3965be25a
ToppCell	(6)_Endothelial-C_(Capillary_Aerocyte_)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	THSD1 N4BP3 DYSF ADRB1 CASKIN2 HECW2 SHANK3 SCARF1 CLEC14A	6.14e-07	193	224	9	f7f2dc6aff02d096a282835094d26d12b3b73e61
ToppCell	proximal-Endothelial-Capillary_Aerocyte\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CARD10 MARCKSL1 THSD1 N4BP3 ADRB1 CASKIN2 HECW2 SCARF1 CLEC14A	6.69e-07	195	224	9	f1cbf82484f489fe7e0b5de6a49ea28d69f04e1a
ToppCell	proximal-Endothelial-Capillary_Aerocyte-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CARD10 MARCKSL1 THSD1 N4BP3 ADRB1 CASKIN2 HECW2 SCARF1 CLEC14A	6.69e-07	195	224	9	13168c9632b58dd65ecb365df3832d95e7325919
ToppCell	proximal-3-Endothelial-Capillary_Aerocyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CARD10 MARCKSL1 THSD1 N4BP3 ADRB1 CASKIN2 HECW2 SCARF1 CLEC14A	6.69e-07	195	224	9	36b2e754ed7ff138ac05fb51f4494e5339669828
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-endo_capillary_(2)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CARD10 THSD1 N4BP3 DYSF ADRB1 CASKIN2 SHANK3 SCARF1 CLEC14A	6.98e-07	196	224	9	2a2a93b89dcb98043cb1f8b422ac8c55e2edc37b
ToppCell	wk_08-11-Endothelial\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CARD10 THSD1 N4BP3 DYSF SULT1A3 SHANK3 SCARF1 SULT1A4 CLEC14A	6.98e-07	196	224	9	0e545874083fd8e954a49fc397d57a86b081008b
ToppCell	Endothelial\|World / Lineage, Cell type, age group and donor	CARD10 THSD1 N4BP3 DYSF CASKIN2 HECW2 SEC14L1 SHANK3 CLEC14A	6.98e-07	196	224	9	96c6d78482a130ce4e29f6629972a06d10d7530e
ToppCell	Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CARD10 THSD1 N4BP3 ADRB1 HECW2 SEC14L1 FAM13C SHANK3 CLEC14A	7.29e-07	197	224	9	b2b7f8dc8ca421441e4c99c4f5d18fbc1668d79f
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature3_(11)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CARD10 THSD1 N4BP3 DYSF ADRB1 CASKIN2 SHANK3 SCARF1 CLEC14A	7.29e-07	197	224	9	a7922f65a8af4a773e4ce80114e4d895a594fa2f
ToppCell	wk_08-11-Endothelial-Blood_vessel_endothelial\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CARD10 THSD1 N4BP3 DYSF SULT1A3 SHANK3 SCARF1 SULT1A4 CLEC14A	7.29e-07	197	224	9	2ed92f942475db6836e48da3c6b8235eb8691c38
ToppCell	wk_15-18-Endothelial-Blood_vessel_endothelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CARD10 THSD1 N4BP3 SULT1A3 HECW2 SHANK3 SCARF1 SULT1A4 CLEC14A	7.29e-07	197	224	9	9b3d6fe76dd7d61a286a28d9466b5f2fece048e1
ToppCell	tumor_Lung-Endothelial_cells-Tip-like_ECs\|tumor_Lung / Location, Cell class and cell subclass	THSD1 DYSF CASKIN2 HECW2 SEC14L1 SHANK3 SCARF1 RFLNB CLEC14A	7.29e-07	197	224	9	353b76ca3e2aa4b8f51396e7121c4baa114083a0
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MARCKSL1 THSD1 DYSF HECW2 RIPOR1 SEC14L1 SCARF1 RFLNB CLEC14A	7.29e-07	197	224	9	15d1e0dffee8f5ba8cee37adfbfa0551a0cd5e15
ToppCell	wk_20-22-Endothelial-Blood_vessel_endothelial-Late_cap\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	THSD1 N4BP3 SULT1A3 CASKIN2 HECW2 SHANK3 SCARF1 SULT1A4 CLEC14A	7.29e-07	197	224	9	797ea1c9f75f88b51fdfc17a2b27ed0199ae64c9
ToppCell	3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DYSF PTPRG CASKIN2 HECW2 FAM13C SHANK3 SCARF1 RFLNB CLEC14A	7.60e-07	198	224	9	e9e98c20ff7b3f3851db86381550ce7085e2db9e
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CARD10 MARCKSL1 THSD1 DYSF HECW2 SHANK3 SCARF1 RFLNB CLEC14A	7.60e-07	198	224	9	4a70a1ab40fe30b90acd97e4e36067db62acc905
ToppCell	wk_20-22-Endothelial-Blood_vessel_endothelial-intermediate_cap\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	THSD1 N4BP3 DYSF SULT1A3 HECW2 SHANK3 SCARF1 SULT1A4 CLEC14A	7.60e-07	198	224	9	a75499f8f1630359b64717c300621aa3b1ab44d4
ToppCell	wk_15-18-Endothelial-Blood_vessel_endothelial-intermediate_cap\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CARD10 THSD1 N4BP3 SULT1A3 HECW2 SHANK3 SCARF1 SULT1A4 CLEC14A	7.60e-07	198	224	9	75270600b5b29187dfa86f01f8f927ae0621cda4
ToppCell	wk_20-22-Endothelial-Blood_vessel_endothelial\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	THSD1 N4BP3 SULT1A3 CASKIN2 HECW2 SHANK3 SCARF1 SULT1A4 CLEC14A	7.93e-07	199	224	9	243b7c72f83c12a34d8ea300fca63b04216268a4
ToppCell	Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SERPINF1 ETV4 ARHGEF17 SSC5D CASKIN1 LTBP4 RARRES1 TBX18 RAB11FIP3	8.26e-07	200	224	9	36de49593cf6ff1c9229fcceb150c1d68658a360
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-1\|TCGA-Kidney / Sample_Type by Project: Shred V9	CDK18 MAPT DYSF KRBA1 HECW2 SHANK3 SCARF1 CLEC14A	1.63e-06	161	224	8	6cacae4a759ace763597ee394cff498dc5d96f74
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CARD10 DYSF HECW2 FAM13C SHANK3 TBX18 RFLNB CLEC14A	1.78e-06	163	224	8	977a970b1296234c22178420294cea73506ee02f
ToppCell	10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-eo/baso/mast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MARCKSL1 HOXA7 PDZD8 NPW BCAN RFLNB SLC45A3 ZFTA	2.66e-06	172	224	8	7fb43b3938b9a3b6935ec22d9d853e7d47b82b3c
ToppCell	droplet-Liver-LIVER-NPC-1m-Endothelial-Hepatocyte_(Pericentral)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPAS3 PTPRG CASKIN2 TMCC2 SHANK3 SCARF1 CLEC14A ZFTA	3.03e-06	175	224	8	98dc3b6f69a29d587f503898f09912700950e3d9
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CDK18 MAPT ARHGEF17 AFAP1L2 FAM13C SYDE1 ZFHX3 MARCKS	3.44e-06	178	224	8	e5e4742e35c3d90f82b830d77bdbdc45828c7deb
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD1 DYSF HECW2 SEC14L1 FAM13C SHANK3 RFLNB CLEC14A	3.58e-06	179	224	8	8f9e538c822940785130297712b75131812a4603
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DYSF ADRB1 CASKIN2 HECW2 SEC14L1 PLEKHG2 SHANK3 HELZ2	3.73e-06	180	224	8	d8ef44710a77ad0fc03243428e5e1dc4d41200cb
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-Activated_DCs\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	MAPT MARCKSL1 MAP3K1 RNF150 TMCC2 SEC14L1 NHSL1 MARCKS	3.73e-06	180	224	8	aae85fb3c92a45614616a3ee3a1af5244cc299a7
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAPT TTC9B MARCKSL1 PGRMC1 AFAP1L2 BCAN PLPP4 CDRT15P3	4.22e-06	183	224	8	8c8ce5a0d5535bef58ac10b7eb726f9c50af2ed8
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CARD10 DYSF CASKIN2 HECW2 SHANK3 SCARF1 RFLNB CLEC14A	4.39e-06	184	224	8	fa38d6a8709f520a027ad7e3ff783c84187ec467
ToppCell	droplet-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC5B DYSF AFAP1L2 TMEM132A WDR62 SHANK3 SLC45A3 JRK	4.57e-06	185	224	8	6a85399cfdb9b89683c874e7f046957f9a601dc2
ToppCell	wk_15-18-Endothelial-Blood_vessel_endothelial-Aerocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CARD10 THSD1 N4BP3 SULT1A3 SHANK3 SCARF1 SULT1A4 HELZ2	4.57e-06	185	224	8	7b3d30a54bec66ca6b0209c86448f4fff97ed75c
ToppCell	droplet-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC5B DYSF AFAP1L2 TMEM132A WDR62 SHANK3 SLC45A3 JRK	4.57e-06	185	224	8	64791056cdbb739136dbef08f4b16e2b5427faad
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	UNC5B NPAS3 CARD10 THSD1 ZNF831 DYSF SHANK3 SLC45A3	4.57e-06	185	224	8	f9f48251bc33eb6bf2cff580d1a3207d21450aa0
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAPT TTC9B CACNA1E CARMIL2 SYT3 APLP1 PLPP4 ECE2	4.75e-06	186	224	8	18fd311252299d6d30ddb32002ed069056108206
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC5B THSD1 DYSF ADRB1 CASKIN2 HECW2 SHANK3 CLEC14A	5.14e-06	188	224	8	73f6ec915934154f435a376cb274b058ff7c5f35
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC5B THSD1 DYSF ADRB1 CASKIN2 HECW2 SHANK3 CLEC14A	5.14e-06	188	224	8	789d1be574e693d7bdd488f3c72c6df788e47b47
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MARCKSL1 STAC2 SAMD4B NCKAP5L FOXP4 RFLNB SMARCA4 LTBP3	5.35e-06	189	224	8	965e0e388251e7318f8b463816dc96ccb4658677
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC5B THSD1 DYSF ADRB1 CASKIN2 HECW2 SHANK3 CLEC14A	5.35e-06	189	224	8	e82211b9dc7540e7a183be2cbcfae39fdf503949
ToppCell	3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THSD1 N4BP3 DYSF SEC14L1 SHANK3 SCARF1 CLEC14A FOXI2	5.35e-06	189	224	8	1d660bceee449aebf12fc9af4c74af246837b27a
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC5B THSD1 DYSF ADRB1 CASKIN2 HECW2 SHANK3 CLEC14A	5.56e-06	190	224	8	a3c6eec6df052105ab78b7e3c78f94218d5912eb
ToppCell	droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SERPINF1 AFAP1L2 LTBP4 C6orf132 MICALL2 MICAL2 LTBP3 PRDM16	5.56e-06	190	224	8	3cf464664d6aa22b212e60b70885953887e92483
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	N4BP3 DYSF ADRB1 CASKIN2 HECW2 SEC14L1 SHANK3 CLEC14A	5.78e-06	191	224	8	1de0bdfd13bd930691564c2673f2e66393bc0255
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UNC5B DYSF ALPK3 SHC1 SHANK3 SCARF1 SLC45A3 MICAL2	6.00e-06	192	224	8	4e63d95f75fe6eb3f817e84528883e95093c5bbd
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD1 ADRB1 PTPRG HECW2 TMCC2 RIPOR1 SHANK3 CLEC14A	6.00e-06	192	224	8	4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC5B THSD1 DYSF ADRB1 CASKIN2 HECW2 SHANK3 CLEC14A	6.00e-06	192	224	8	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MARCKSL1 THSD1 DYSF ADRB1 HECW2 SHANK3 RFLNB CLEC14A	6.00e-06	192	224	8	0aeb5351275c0a91151ea2d52b2cdde172da6731
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	N4BP3 DYSF ADRB1 CASKIN2 HECW2 SEC14L1 SHANK3 CLEC14A	6.00e-06	192	224	8	7197e401e563441ab94815f7619e032ebef9e586
ToppCell	PCW_05-06-Endothelial-Endothelial_mature-endo_capillary_(2)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CARD10 THSD1 N4BP3 DYSF CASKIN2 SHANK3 SCARF1 CLEC14A	6.24e-06	193	224	8	4f38aae346ea3b4258744e9dc1e5aeb4fea13d06
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DYSF ADRB1 PTPRG CASKIN2 HECW2 SEC14L1 SHANK3 CLEC14A	6.24e-06	193	224	8	f582e939e3e08a8a3f71deec78c33715be8faa51
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC5B THSD1 DYSF ADRB1 CASKIN2 HECW2 SHANK3 CLEC14A	6.48e-06	194	224	8	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	TCGA-Adrenal-Primary_Tumor-Pheochromocytoma\|TCGA-Adrenal / Sample_Type by Project: Shred V9	MAPT UNC5B GPR173 ARHGEF17 TTBK1 PDZD4 APLP1 SHF	6.48e-06	194	224	8	b6488bc3a8905e926ad298332963e1bbaf010046
ToppCell	TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma\|TCGA-Adrenal / Sample_Type by Project: Shred V9	MAPT UNC5B GPR173 ARHGEF17 TTBK1 PDZD4 APLP1 SHF	6.48e-06	194	224	8	1e1f4139ad584f493d75a9b7f1568eca4653c5a2
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UNC5B THSD1 DYSF ADRB1 CASKIN2 HECW2 SHANK3 CLEC14A	6.48e-06	194	224	8	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	wk_20-22-Endothelial-Blood_vessel_endothelial-Aerocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	THSD1 N4BP3 SULT1A3 CASKIN2 HECW2 SHANK3 SULT1A4 CLEC14A	6.48e-06	194	224	8	54b7126b83f7482227aeaea065f504b65fa34bfe
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-endo_capillary_(2)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CARD10 THSD1 N4BP3 DYSF CASKIN2 SHANK3 SCARF1 CLEC14A	6.48e-06	194	224	8	3c31ac44e8cf4eca3ba7b8bfc05ad3e96a970956
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RIN3 DYSF CASKIN2 HECW2 SEC14L1 SHANK3 CLEC14A MARCKS	6.48e-06	194	224	8	ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7
ToppCell	wk_08-11-Endothelial-Blood_vessel_endothelial-intermediate_cap\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	THSD1 N4BP3 DYSF SULT1A3 SHANK3 SCARF1 SULT1A4 CLEC14A	6.73e-06	195	224	8	c0ea25ed1a849e6efff885e98013a4f1d5134758
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MARCKSL1 THSD1 ADRB1 CASKIN2 HECW2 SCARF1 CLEC14A MARCKS	6.73e-06	195	224	8	e8992c549dad9a88d2b8d01039a8d02a950b29b4
ToppCell	facs-Skin-nan-18m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MARCKSL1 THSD1 MAP3K1 FAM13C HEXIM1 RFLNB LTBP3 MARCKS	6.73e-06	195	224	8	ba7cb80deb872c9184769f0dd57855c3c6a432bf
ToppCell	PCW_13-14-Endothelial-Endothelial_cycling-endo_proliferating1_(10)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CARD10 THSD1 N4BP3 DYSF ADRB1 SHANK3 SCARF1 CLEC14A	6.98e-06	196	224	8	b826dce5b3daa8eb3d4a530b9564de58d9ce3767
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RIN3 DYSF PTPRG CASKIN2 HECW2 SEC14L1 SHANK3 CLEC14A	6.98e-06	196	224	8	48b4a9cea97a55190217deaf51bf867608c5a9a7
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RIN3 DYSF PTPRG CASKIN2 HECW2 SEC14L1 SHANK3 CLEC14A	6.98e-06	196	224	8	473980c827443464d08a0be28c53e3536369b12a
ToppCell	11.5-Airway-Endothelial\|Airway / Age, Tissue, Lineage and Cell class	CARD10 THSD1 N4BP3 DYSF SHANK3 SCARF1 RFLNB CLEC14A	6.98e-06	196	224	8	e7d55933e23599122e20498548abf5b30fc25c8f
ToppCell	distal-Hematologic-Plasmacytoid_Dendritic-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SERPINF1 PRAG1 ZNF469 ANKRD30BL CARMIL2 BEAN1 TLR9 SLC4A3	6.98e-06	196	224	8	170629b9ae82e9a911b93e8739dcd38176fbecb4
ToppCell	CV-Moderate-6\|CV / Virus stimulation, Condition and Cluster	MARCKSL1 ZBTB7A GNAS GTF3C1 RFLNB IL21R ANKRD11 ARHGAP45	6.98e-06	196	224	8	7bced0cc2112697593c478fa291b8ed3941fb811
ToppCell	11.5-Airway-Endothelial-Endothelial\|Airway / Age, Tissue, Lineage and Cell class	CARD10 THSD1 N4BP3 DYSF SHANK3 SCARF1 RFLNB CLEC14A	6.98e-06	196	224	8	509ddea8d6e1d0b832f69490ab8a736af4ca19a8
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RIN3 DYSF PTPRG CASKIN2 HECW2 SEC14L1 SHANK3 CLEC14A	6.98e-06	196	224	8	8f2031b1a9232c389517fbf3c29f47f9468b0077
ToppCell	wk_15-18-Endothelial-Lymph_endothelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	UNC5B CARD10 THSD1 DYSF SHC1 SHANK3 SCARF1 SLC45A3	6.98e-06	196	224	8	ff627244d7f5fd6a2ec009dae32d3509f0e2d95e
ToppCell	Endothelial-capillary_endothelial_cell_(Cap1)\|World / Lineage, Cell type, age group and donor	THSD1 N4BP3 DYSF CASKIN2 HECW2 SEC14L1 SHANK3 CLEC14A	6.98e-06	196	224	8	0ce3ed27d2b9276390952652c17a8d6de13add36
ToppCell	proximal-Endothelial-Capillary-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	THSD1 N4BP3 ADRB1 HECW2 SEC14L1 BRME1 SHANK3 CLEC14A	7.25e-06	197	224	8	ddb8ea895f0f34d4f20a0740b708fa0f3e378801
ToppCell	3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UNC5B THSD1 N4BP3 DYSF SEC14L1 SHANK3 SCARF1 CLEC14A	7.25e-06	197	224	8	98e34e8612f111bb667a574de1faaa785d318ca4
ToppCell	PCW_13-14-Endothelial-Endothelial_immature-endo_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CARD10 THSD1 N4BP3 DYSF ADRB1 SHANK3 SCARF1 CLEC14A	7.25e-06	197	224	8	4e9221cb02122aed2981c3c9157e847a3710e323
ToppCell	proximal-Endothelial-Capillary\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	THSD1 N4BP3 ADRB1 HECW2 SEC14L1 BRME1 SHANK3 CLEC14A	7.25e-06	197	224	8	53baef54bd85c60ae24a3c163b3a3d937fb6ff0b
ToppCell	(4)_Endothelial_cells-(41)_EC-arteriolar\|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis	UNC5B SERPINF1 N4BP3 PTPRG GNAS LTBP4 FAM13C RFLNB	7.25e-06	197	224	8	482e3f8926880afed88ed37553ed2b5ed58b8c99
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CARD10 MARCKSL1 THSD1 DYSF HECW2 SHANK3 SCARF1 CLEC14A	7.25e-06	197	224	8	dfc052a447c3b32235fcaffdf06c4e0941723d19
ToppCell	PCW_13-14-Endothelial-Endothelial_immature-endo_immature3_(11)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CARD10 THSD1 N4BP3 DYSF CASKIN2 SHANK3 SCARF1 CLEC14A	7.25e-06	197	224	8	21a1080e1db3a64f3eccc7aed2b3189332d31038
Drug	fullerene C60	VWA5B2 ZXDC CDK18 PDE4C TSPOAP1 ETV4 MCM2 CARD10 MARCKSL1 THSD1 N4BP3 REXO1 ADD1 MAP3K1 STAC2 ADRB1 CASKIN2 HECW2 PIK3R2 TMCC2 PPP1R37 RIPOR1 ARHGAP25 FGFR4 DEK WNK4 SEC14L1 CACNA1E B4GALNT4 BEAN1 SAMD4B PLEKHG2 AKT1S1 SHANK3 GTF3C1 PRICKLE3 WDR6 IL21R HELZ2 SMARCA4 MYBPC3	6.87e-10	1498	216	41	ctd:C069837
Drug	Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	CDK18 RIN3 SERPINF1 NPAS3 THSD1 ARHGEF17 CIC TMCC2 RIPOR1 LTBP4 PGGHG PRR36	3.82e-07	195	216	12	4180_DN
Drug	Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A	SERPINF1 EPS8L1 N4BP3 CCNK CIC ZBTB7A WIZ MAP3K9 LTBP4 SLC4A2 MAP1S RAB11FIP3	4.04e-07	196	216	12	3327_DN
Drug	Mifepristone [84371-65-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	ASXL1 PPP1R13L CIC AXIN1 WIZ CASKIN2 SSH3 OGFRL1 SLC4A2 MAP1S WDR6 ARHGAP45	4.04e-07	196	216	12	7183_DN
Drug	Methimazole [60-56-0]; Up 200; 35uM; PC3; HT_HG-U133A	CDK18 PDE4C CEL NPAS3 ARHGEF17 CIC LTBP4 SYDE1 KMT2D EHMT1 PRDM16 RAB11FIP3	4.26e-07	197	216	12	3815_UP
Drug	Solasodine [126-17-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	CDK18 EPS8L1 THSD1 ZZEF1 ARHGEF17 SSH3 LTBP4 PRR36 APLP1 SMG5 PITPNM1 TNFRSF8	4.26e-07	197	216	12	3924_DN
Drug	Zalcitabine [7481-89-2]; Down 200; 19uM; MCF7; HT_HG-U133A	RIN3 MAPT SPAG8 CASKIN2 SSH3 CAMSAP1 LTBP4 ARAP1 PRR36 RHOT2 MICAL2 ZFHX3	4.75e-07	199	216	12	4799_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A	MAPT SPAG8 ZZEF1 AXIN1 WIZ SSH3 SYDE1 GAS2L1 PRICKLE3 ZFHX3 RAB11FIP3	2.62e-06	194	216	11	4242_DN
Drug	clofibrate; Up 200; 150uM; MCF7; HG-U133A	CCNK AXIN1 WIZ CASKIN2 MCM3AP PPP1R37 DMWD GOLGA2 GAS2L1 IL21R MYBPC3	2.62e-06	194	216	11	263_UP
Drug	Bacitracin [1405-87-4]; Up 200; 2.8uM; MCF7; HT_HG-U133A	UNC5B EPS8L1 DYSF CIC FGFR4 ARAP1 OGFRL1 SYDE1 PITPNM1 SLC19A1 EHMT1	2.76e-06	195	216	11	7448_UP
Drug	Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HG-U133A	ASXL1 CARD10 DYSF P3H1 PIK3R2 MCM3AP SKAP2 OGFRL1 ZNF473 GTF3C1 ANKRD11	2.76e-06	195	216	11	1886_DN
Drug	0179445-0000 [211246-22-9]; Down 200; 1uM; PC3; HT_HG-U133A	AXIN1 CASKIN2 SSH3 PHLPP1 ARAP1 MGRN1 HIVEP3 PRICKLE3 SLC19A1 ZFHX3 RAB11FIP3	2.90e-06	196	216	11	4292_DN
Drug	Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; PC3; HT_HG-U133A	ASXL1 RREB1 SSH3 TMCC2 RIPOR1 NR1H2 GOLGA2 ZNF473 SMG5 ZNF335 SMARCA4	3.04e-06	197	216	11	5865_DN
Drug	Minoxidil [38304-91-5]; Down 200; 19.2uM; MCF7; HT_HG-U133A	SPAG8 WIZ P3H1 MAP3K9 RIPOR1 LTBP4 ARAP1 PRR36 RHOT2 HIVEP3 MAP1S	3.19e-06	198	216	11	4800_DN
Drug	Clioquinol [130-26-7]; Down 200; 13uM; MCF7; HT_HG-U133A	MAPT KREMEN2 EPS8L1 ARHGEF17 ZBTB7A PLEKHM2 FGFR4 GNAS HEXIM1 MAP1S SLC19A1	3.19e-06	198	216	11	5258_DN
Drug	Theophylline monohydrate [5967-84-0]; Up 200; 20.2uM; MCF7; HT_HG-U133A	SPAG8 MCM3AP GNAS DMWD WDR62 ARAP1 PGGHG PRR36 SYDE1 TNFRSF8 RAB11FIP3	3.19e-06	198	216	11	4812_UP
Drug	CP-690334-01 [459212-38-5]; Down 200; 1uM; MCF7; HT_HG-U133A	UNC5B SERPINF1 CIC RIPOR1 ZNF473 PGGHG HCN4 PRR36 DDX51 AATK EHMT1	3.35e-06	199	216	11	4383_DN
Drug	rofecoxib; Up 200; 10uM; MCF7; HG-U133A	KREMEN2 NPAS3 DYSF ZBTB7A RIPOR1 LTBP4 LMTK2 GAS2L1 ZNF335 ARHGAP45 PRDM16	3.52e-06	200	216	11	251_UP
Drug	geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A_EA	ZXDC CARD10 PLEKHM2 CASKIN2 RIPOR1 ARAP1 SEC14L1 RHOT2 GAS2L1 RAB11FIP3	1.51e-05	191	216	10	1008_DN
Drug	Tetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; MCF7; HT_HG-U133A	RIN3 CIC PLEKHM2 NR1H2 LTBP4 WDR62 ARAP1 SMG5 SYDE1 RAB11FIP3	1.73e-05	194	216	10	6769_UP
Drug	Epivincamine [6835-99-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A	CDK18 PDE4C CIC ARAP1 OGFRL1 SYDE1 MAP1S SLC19A1 MYBPC3 RAB11FIP3	1.73e-05	194	216	10	2775_UP
Drug	Cyanocobalamin [68-19-9]; Up 200; 3uM; MCF7; HT_HG-U133A	PDE4C CIC SSH3 PHLPP1 RIPOR1 FGFR4 DMWD LTBP4 DGKD PRDM16	1.89e-05	196	216	10	3252_UP
Drug	Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; MCF7; HT_HG-U133A	CDK18 ARHGEF17 WIZ PLEKHM2 FGFR4 WDR62 PRR36 PRICKLE3 SLC19A1 ZFHX3	1.89e-05	196	216	10	6273_UP
Drug	Pyrimethamine [58-14-0]; Down 200; 16uM; MCF7; HT_HG-U133A	RIN3 EPS8L1 DYSF CIC WIZ PLEKHM2 SSH3 MAP3K9 ARAP1 RHOT2	1.89e-05	196	216	10	4779_DN
Drug	Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; PC3; HT_HG-U133A	SPAG8 GOLGA2 ARAP1 BCAN SMG5 SLC4A3 GAS2L1 AATK PRICKLE3 SLC19A1	1.89e-05	196	216	10	4591_DN
Drug	Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A	CDK18 CEL KREMEN2 THSD1 CIC CAMSAP1 DMWD WDR62 HIVEP3 EHMT1	1.97e-05	197	216	10	2235_DN
Drug	Cyclacillin [3485-14-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	EPS8L1 THSD1 HOXA7 ZBTB7A PLEKHM2 GNAS WDR62 BCAN RHOT2 SYDE1	1.97e-05	197	216	10	3800_DN
Drug	Ampyrone [83-07-8]; Down 200; 19.6uM; HL60; HG-U133A	ASXL1 PGRMC1 PLEKHM2 MCM3AP RHOT2 HEXIM1 AATK WDR6 SMARCA4 ARHGAP45	1.97e-05	197	216	10	1402_DN
Drug	Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A	MAPT EPS8L1 THSD1 CASKIN2 SSH3 ARAP1 OGFRL1 HEXIM1 HIVEP3 MICALL2	1.97e-05	197	216	10	6456_DN
Drug	Azacyclonol [115-46-8]; Down 200; 15uM; HL60; HG-U133A	ASXL1 PGRMC1 PLEKHM2 MCM3AP RHOT2 SMG5 HEXIM1 PITPNM1 WDR6 SMARCA4	2.06e-05	198	216	10	2020_DN
Drug	Lactobionic acid [96-82-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	KREMEN2 CIC AXIN1 WIZ RIPOR1 ARAP1 APLP1 SLC4A2 MAP1S EHMT1	2.06e-05	198	216	10	3246_DN
Drug	Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; PC3; HG-U133A	DYSF P3H1 SSH3 MAP3K9 DPH2 RHOT2 SLC4A2 GAS2L1 GTF3C1 ANKRD11	2.15e-05	199	216	10	1901_DN
Drug	Vidarabine [5536-17-4]; Down 200; 15uM; MCF7; HT_HG-U133A	MAPT KREMEN2 AXIN1 ZBTB7A WIZ TMEM132A RIPOR1 SMG5 ARHGAP45 RAB11FIP3	2.15e-05	199	216	10	7203_DN
Drug	Ethoxyquin [91-53-2]; Up 200; 18.4uM; PC3; HT_HG-U133A	PDE4C TSPOAP1 SPAG8 CCNK CASKIN2 DMWD WDR62 PRR36 BRME1 ADGB	2.15e-05	199	216	10	3764_UP
Drug	Estriol [50-27-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A	PPP1R13L CASKIN2 RIPOR1 MICALL2 ZNF335 SMARCA4 ZFHX3 ARHGAP45 RAB11FIP3	9.15e-05	191	216	9	7220_DN
Drug	LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A	EPS8L1 PLEKHM2 RIPOR1 FGFR4 SYDE1 HEXIM1 PRICKLE3 SLC19A1 ARHGAP45	9.90e-05	193	216	9	1664_DN
Drug	trichostatin A; Down 200; 0.1uM; ssMCF7; HG-U133A	ASXL1 AKAP8 SERPINF1 EPS8L1 DYSF AXIN1 WIZ SMG5 SLC19A1	9.90e-05	193	216	9	413_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	MAPT KREMEN2 CIC PIK3R2 RIPOR1 WDR62 SLC19A1 ZNF335 ARHGAP45	9.90e-05	193	216	9	5239_DN
Drug	Simvastatin [79902-63-9]; Down 200; 9.6uM; PC3; HT_HG-U133A	SPAG8 ADD1 AXIN1 ZBTB7A WIZ SSH3 GOLGA2 GAS2L1 RAB11FIP3	1.03e-04	194	216	9	4244_DN
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A	CEL KREMEN2 ZZEF1 LTBP4 WDR62 APLP1 SMG5 ARHGEF10L HIVEP3	1.03e-04	194	216	9	4763_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A	CDK18 UNC5B N4BP3 CIC SSH3 MAP3K9 CAMSAP1 LTBP4 PRR36	1.03e-04	194	216	9	3969_DN
Drug	Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A	CIC ZBTB7A CASKIN2 MICAL3 LTBP4 DGKD SLC4A2 ARHGAP45 RAB11FIP3	1.03e-04	194	216	9	1707_DN
Drug	Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A	CEL UNC5B WIZ CASKIN2 GOLGA2 RHOT2 PITPNM1 GTF3C1 EHMT1	1.03e-04	194	216	9	2221_DN
Drug	Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	KREMEN2 AXIN1 WIZ PLEKHM2 WDR62 ARAP1 SEC14L1 RHOT2 PITPNM1	1.03e-04	194	216	9	3867_DN
Drug	LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A	EPS8L1 MAP3K1 ZBTB7A CASKIN2 RIPOR1 HEXIM1 MICALL2 SLC19A1 RAB11FIP3	1.03e-04	194	216	9	5587_DN
Drug	5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA	KREMEN2 THSD1 GADD45A AXIN1 FGFR4 ZNF473 PRR36 FBXO46 PITPNM1	1.07e-04	195	216	9	834_UP
Drug	Tetrandrine [518-34-3]; Down 200; 6.4uM; MCF7; HT_HG-U133A	RIN3 THSD1 DYSF ZBTB7A WIZ PLEKHM2 FGFR4 ARAP1 EHMT1	1.07e-04	195	216	9	6082_DN
Drug	Ursolic acid [77-52-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	SERPINF1 DYSF ZBTB7A CASKIN2 FGFR4 CAMSAP1 LTBP4 HIVEP3 PRICKLE3	1.07e-04	195	216	9	2230_DN
Drug	retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A	EPS8L1 PPP1R13L ADD1 SSH3 NR1H2 GOLGA2 OGFRL1 GAS2L1 ZNF335	1.07e-04	195	216	9	6971_DN
Drug	Diprophylline [479-18-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	TSPOAP1 THSD1 SPAG8 CASKIN2 SSH3 FGFR4 ARAP1 TNFRSF8 ZFHX3	1.11e-04	196	216	9	5063_DN
Drug	Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; MCF7; HT_HG-U133A	SERPINF1 DYSF ZBTB7A WIZ PHLPP1 RIPOR1 WDR62 ARAP1 ZNF473	1.11e-04	196	216	9	3199_DN
Drug	Mifepristone [84371-65-3]; Down 200; 9.4uM; HL60; HG-U133A	EPS8L1 ZBTB7A CAMSAP1 SEC14L1 OGFRL1 DGKD RHOT2 HEXIM1 HIVEP3	1.11e-04	196	216	9	1569_DN
Drug	Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	EPS8L1 SPAG8 DYSF SSH3 WDR62 ZNF473 SMG5 GAS2L1 PRICKLE3	1.11e-04	196	216	9	7353_DN
Drug	Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; PC3; HT_HG-U133A	RIN3 MAPT EPS8L1 CASKIN2 PIK3R2 MCM3AP TMEM132A MICAL3 AATK	1.11e-04	196	216	9	4494_DN
Drug	genistein; Up 200; 10uM; MCF7; HT_HG-U133A	CARD10 EPS8L1 SPAG8 CAMSAP1 WDR62 ARAP1 PRR36 RHOT2 SCARF1	1.11e-04	196	216	9	5232_UP
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A	EPS8L1 CIC WIZ PHLPP1 LTBP4 SMG5 PRICKLE3 SLC19A1 SMARCA4	1.11e-04	196	216	9	4826_DN
Drug	Alcuronium chloride [15180-03-7]; Down 200; 5.4uM; MCF7; HT_HG-U133A	UNC5B KREMEN2 ARHGEF17 CIC MAP3K1 CAMSAP1 ARAP1 DDX51 FBXO46	1.11e-04	196	216	9	4409_DN
Drug	Buspirone hydrochloride [33386-08-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A	CEL EPS8L1 TMCC2 FGFR4 HCN4 FAM13C PITPNM1 SLC19A1 MYBPC3	1.16e-04	197	216	9	2637_UP
Drug	Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; HL60; HT_HG-U133A	TSPOAP1 EPS8L1 SSH3 NR1H2 MICAL3 GOLGA2 SMG5 GAS2L1 MICALL2	1.16e-04	197	216	9	2972_DN
Drug	Levopropoxyphene napsylate [5714-90-9]; Up 200; 7.4uM; PC3; HT_HG-U133A	PDE4C CEL ZZEF1 MAP3K1 WDR62 SHANK1 FAM13C HIVEP3 GAS2L1	1.16e-04	197	216	9	5083_UP
Drug	Clopamide [636-54-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A	CIC ZBTB7A MAP3K9 GOLGA2 APLP1 MAP1S MICALL2 EHMT1 RAB11FIP3	1.16e-04	197	216	9	5402_DN
Drug	rapamycin; Down 200; 0.1uM; HL60; HG-U133A	ZZEF1 AXIN1 WIZ GOLGA2 SMG5 KMT2D AATK GTF3C1 EHMT1	1.16e-04	197	216	9	362_DN
Drug	Thioridazine hydrochloride [130-61-0]; Down 200; 9.8uM; MCF7; HT_HG-U133A	RIN3 THSD1 CASKIN2 TMCC2 FGFR4 LTBP4 PRR36 APLP1 MICAL2	1.16e-04	197	216	9	4164_DN
Drug	Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; PC3; HT_HG-U133A	THSD1 ZBTB7A CASKIN2 PIK3R2 TMEM132A MAP3K9 RHOT2 PITPNM1 HIVEP3	1.16e-04	197	216	9	4658_DN
Drug	Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A	UNC5B KREMEN2 CASKIN2 MCM3AP ZNF473 FBXO46 MAP1S PRICKLE3 ZFHX3	1.16e-04	197	216	9	7186_DN
Drug	valdecoxib; Up 200; 10uM; PC3; HT_HG-U133A	CEL MAPT CCNK ZBTB7A ARHGAP25 CAMSAP1 SHANK1 BCAN MICAL2	1.16e-04	197	216	9	6378_UP
Drug	Prednisone [53-03-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	TSPOAP1 MAPT PIK3R2 WDR62 DDX51 BCAN HIVEP3 SLC19A1 EHMT1	1.16e-04	197	216	9	4577_DN
Drug	Ethisterone [434-03-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A	SERPINF1 ZBTB7A WIZ TMCC2 PPP1R37 LTBP4 BCAN HIVEP3 IL21R	1.20e-04	198	216	9	3864_UP
Drug	Trimethadione [127-48-0]; Down 200; 28uM; HL60; HT_HG-U133A	RIN3 PDE4C EPS8L1 RIPOR1 ARAP1 SEC14L1 SYDE1 PITPNM1 AATK	1.20e-04	198	216	9	2486_DN
Drug	Isocarboxazid [59-63-2]; Up 200; 17.2uM; MCF7; HT_HG-U133A	CDK18 PDE4C CCNK MAP3K9 GOLGA2 RAPGEF1 GAS2L1 TNFRSF8 PRDM16	1.20e-04	198	216	9	4706_UP
Drug	Homosalate [118-56-9]; Up 200; 15.2uM; PC3; HT_HG-U133A	EPS8L1 ARHGEF17 CIC LTBP4 PGGHG SCARF1 ADGB TNFRSF8 IL21R	1.20e-04	198	216	9	3797_UP
Drug	Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; MCF7; HT_HG-U133A	MAPT SSH3 CAMSAP1 GOLGA2 PRR36 FBXO46 HEXIM1 MICALL2 PRICKLE3	1.20e-04	198	216	9	4791_DN
Drug	Nifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A	EPS8L1 CIC WIZ CASKIN2 PIK3R2 NR1H2 PITPNM1 ZNF335 ZFHX3	1.20e-04	198	216	9	6016_DN
Drug	Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; HL60; HT_HG-U133A	EPS8L1 AXIN1 ZBTB7A NR1H2 ARAP1 SMG5 SYDE1 PITPNM1 MAP1S	1.20e-04	198	216	9	2398_DN
Drug	nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A	PLEKHM2 CASKIN2 SSH3 MCM3AP GOLGA2 SMG5 SYDE1 SLC4A2 MICAL2	1.20e-04	198	216	9	6983_DN
Drug	SC 19220; Up 200; 10uM; PC3; HT_HG-U133A	ADD1 CASKIN2 TMCC2 NR1H2 CAMSAP1 APLP1 SMG5 HEXIM1 SLC19A1	1.20e-04	198	216	9	7095_UP
Drug	Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ZXDC MAPT KREMEN2 PPP1R13L ZBTB7A RHOT2 SMG5 ZNF335 MARCKS	1.25e-04	199	216	9	7192_DN
Drug	nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A	MAPT ZZEF1 MAP3K1 ARAP1 ZNF473 ADGB HIVEP3 MICALL2 PRICKLE3	1.25e-04	199	216	9	2683_DN
Drug	Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; PC3; HT_HG-U133A	RIN3 CARD10 AXIN1 HOXA7 SSH3 TMCC2 TMEM132A HIVEP3 SLC19A1	1.25e-04	199	216	9	6693_DN
Drug	Suramin sodium salt; Down 200; 10uM; MCF7; HT_HG-U133A	UNC5B SPAG8 N4BP3 DYSF GADD45A WIZ LMTK2 APLP1 PITPNM1	1.25e-04	199	216	9	7524_DN
Drug	Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	CIC MCM3AP RIPOR1 MICAL3 LTBP4 ARAP1 SLC19A1 ZFHX3 ARHGAP45	1.25e-04	199	216	9	7439_UP
Drug	Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A	CEL KREMEN2 SERPINF1 EPS8L1 CIC WIZ SSH3 TMCC2 RAB11FIP3	1.25e-04	199	216	9	2231_DN
Drug	Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A	ZXDC AXIN1 CASKIN2 SSH3 TMEM132A RIPOR1 RHOT2 GAS2L1 MICAL2	1.25e-04	199	216	9	6214_DN
Drug	Methamphetamine	PCNX3 MAPT THSD1 SPAG8 DYSF ZZEF1 REXO1 CIC PLEKHM2 ASPM PHLPP1 RNF225 MICAL3 DMWD QARS1 LTBP4 SEC14L1 HTR6 SYT3 PGGHG HCN4 PLEKHG2 SLC4A3 SHF PRICKLE3 ANKRD11 PRDM16 MYBPC3	1.56e-04	1401	216	28	ctd:D008694
Drug	Gln-KPA	AARS1 QARS1	2.67e-04	3	216	2	CID016066761
Drug	Glu-KPA	AARS1 QARS1	2.67e-04	3	216	2	CID016066759
Drug	resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA	CARD10 SSH3 ASPM RHOT2 HEXIM1 PRICKLE3 SLC19A1 RAB11FIP3	2.98e-04	177	216	8	841_DN
Drug	Gossypol [303-45-7]; Up 200; 7.8uM; MCF7; HT_HG-U133A	CDK18 UNC5B NPAS3 N4BP3 ZZEF1 GADD45A HIVEP3 IL21R	3.34e-04	180	216	8	3637_UP
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A	WIZ MAP3K9 DMWD BCAN RHOT2 SLC19A1 IL21R ZFHX3	4.78e-04	190	216	8	4274_UP
Drug	5253409; Up 200; 17uM; MCF7; HT_HG-U133A_EA	KREMEN2 GADD45A MAP3K1 PLEKHM2 CAMSAP1 WDR62 PRR36 SMG5	4.78e-04	190	216	8	961_UP
Drug	thioridazine hydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	MAPT UNC5B PIK3R2 MCM3AP LTBP4 ZNF473 HIVEP3 SMARCA4	4.95e-04	191	216	8	4454_DN
Drug	LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A	KREMEN2 CASKIN2 MCM3AP MICAL3 FGFR4 RHOT2 HEXIM1 SLC19A1	5.13e-04	192	216	8	5596_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	EPS8L1 AXIN1 WIZ PGGHG SMG5 FBXO46 HIVEP3 SLC19A1	5.13e-04	192	216	8	2450_DN
Drug	LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A	CARD10 EPS8L1 RIPOR1 FGFR4 PRR36 SMG5 ARHGEF10L SLC19A1	5.13e-04	192	216	8	1661_DN
Drug	Cefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A	CDK18 KREMEN2 THSD1 WIZ PLEKHM2 CAMSAP1 PRR36 APLP1	5.31e-04	193	216	8	4161_DN
Drug	Cefalonium [5575-21-3]; Down 200; 8.8uM; PC3; HT_HG-U133A	MAPT SPAG8 ZZEF1 ZBTB7A WIZ SMG5 GAS2L1 ZFHX3	5.31e-04	193	216	8	4245_DN
Drug	CP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A	RIN3 EPS8L1 WIZ MCM3AP WDR62 SEC14L1 RHOT2 SMARCA4	5.31e-04	193	216	8	3906_DN
Drug	Clozapine [5786-21-0]; Up 200; 12.2uM; PC3; HT_HG-U133A	EPS8L1 DMWD GOLGA2 ARAP1 DDX51 SYDE1 ADGB MYBPC3	5.31e-04	193	216	8	4670_UP
Drug	Ethacrynic acid [58-54-8]; Down 200; 13.2uM; MCF7; HT_HG-U133A	SERPINF1 PIK3R2 MCM3AP ARAP1 ARHGEF10L PITPNM1 MAP1S MARCKS	5.31e-04	193	216	8	3181_DN
Drug	Zidovudine, AZT [30516-87-1]; Down 200; 15uM; PC3; HT_HG-U133A	MAPT SPAG8 AXIN1 ZBTB7A PIK3R2 SSH3 PRICKLE3 ZFHX3	5.31e-04	193	216	8	6733_DN
Disease	obsolete aging, cognition	PRR20C PRR20D PRR20B PRR20E PRR20A	5.81e-08	15	217	5	EFO_0003925, GO_0007568
Disease	mosaic loss of chromosome Y measurement	PRR20C KRBA1 PRR20D PRR20B PRR20E PRR20A PRDM16	2.13e-06	80	217	7	EFO_0007783
Disease	t-tau:beta-amyloid 1-42 ratio measurement	UNC5B PRR20C PRR20D PRR20B PRR20E PRR20A	9.28e-06	66	217	6	EFO_0007708
Disease	Alzheimer's disease (implicated_via_orthology)	MAPT SERPINF1 APLP1 HIVEP3 TM2D2	6.30e-05	57	217	5	DOID:10652 (implicated_via_orthology)
Disease	Tinnitus, wellbeing measurement	PRR20C PRR20D PRR20B PRR20E PRR20A FOXI2	7.89e-05	96	217	6	EFO_0007869, HP_0000360
Disease	telomere length	PRR20C PRR20D PRR20B PRR20E PRR20A RAPGEF1 PITPNM1 HIVEP3 MICAL2 PRRT1B	1.17e-04	313	217	10	EFO_0004505
Disease	Left ventricular noncompaction	PLEKHM2 PRDM16 MYBPC3	1.34e-04	14	217	3	C1960469
Disease	congenital heart disease (implicated_via_orthology)	UBE2A USP42 CHD6 KMT2D MYBPC3	1.57e-04	69	217	5	DOID:1682 (implicated_via_orthology)
Disease	Autosomal recessive primary microcephaly	ASPM WDR62 ZNF335	1.67e-04	15	217	3	cv:C3711387
Disease	alkaline phosphatase measurement	RIN3 PDE4C AKAP8 CEL MAPT RREB1 PRAG1 AXIN1 ZBTB7A UBE2A CASKIN1 PPP1R37 MICAL3 ARHGAP25 B4GALNT4 PGGHG HIVEP3 LTBP3 MYBPC3	1.97e-04	1015	217	19	EFO_0004533
Disease	Prostatic Neoplasms	SERPINF1 ETV4 PGRMC1 GADD45A MAP3K1 ZBTB7A PIK3R2 CHD6 FGFR4 LMTK2 SLC4A2 FOXP4 KMT2D ZFHX3	2.05e-04	616	217	14	C0033578
Disease	Malignant neoplasm of prostate	SERPINF1 ETV4 PGRMC1 GADD45A MAP3K1 ZBTB7A PIK3R2 CHD6 FGFR4 LMTK2 SLC4A2 FOXP4 KMT2D ZFHX3	2.05e-04	616	217	14	C0376358
Disease	reticulocyte measurement	MAPT RREB1 MAP3K1 ZNF469 ADRB1 WIZ ATP11B USP42 TMCC2 USP4 ARHGAP25 FLVCR1 SCARF1 USP10 FOXP4 MICAL2 SLC19A1 ARHGAP45 PRDM16	3.11e-04	1053	217	19	EFO_0010700
Disease	gastric adenocarcinoma	CHD6 JRK	3.20e-04	4	217	2	EFO_0000503
Disease	PR interval	PCNX3 DYSF ZNF469 ADRB1 CASKIN2 ALPK3 CHD6 DEK HCN4 HIVEP3 MICAL2 MARCKS	3.28e-04	495	217	12	EFO_0004462
Disease	stem Cell Growth Factor-beta measurement	SHANK1 RAB11FIP3	5.31e-04	5	217	2	EFO_0802090
Disease	Metastatic melanoma	TTBK1 ALPK3 MAP3K9 WNK4	6.75e-04	54	217	4	C0278883
Disease	stroke	TTBK1 PTPRG C4orf54 MICAL2 SMARCA4 ZFHX3	7.08e-04	144	217	6	EFO_0000712
Disease	FEV/FEC ratio	ASXL1 RREB1 ARHGEF17 MAP3K1 HOXA7 PRR12 UBE2A RIPOR1 MICAL3 FGFR4 SKAP2 LTBP4 ARAP1 DGKD HIVEP3 SLC19A1 ANKRD11 ZFHX3 LTBP3 PRDM16	7.88e-04	1228	217	20	EFO_0004713
Disease	stem cell growth factor-alpha measurement	SHANK1 RAB11FIP3	1.10e-03	7	217	2	EFO_0020754
Disease	duodenal ulcer, gastric ulcer	GNAS JRK	1.10e-03	7	217	2	EFO_0004607, EFO_0009454
Disease	blood vanadium measurement	GNAS B4GALNT4 TBX18	1.38e-03	30	217	3	EFO_0021533
Disease	caudate nucleus volume	NPAS3 ZFHX3 PRDM16	1.38e-03	30	217	3	EFO_0004830
Disease	Sudden Cardiac Death	PPP1R13L MYBPC3	1.46e-03	8	217	2	C0085298
Disease	diastolic blood pressure, systolic blood pressure	RBBP8NL GADD45A ADD1 AFAP1L2 CHD6 SKAP2 WDR62 HCN4 FAM13C SYDE1 TBX18 DNLZ ZFHX3	1.47e-03	670	217	13	EFO_0006335, EFO_0006336
Disease	Large cell carcinoma of lung	TTBK1 ALPK3 LMTK2	1.66e-03	32	217	3	C0345958
Disease	microcephaly (implicated_via_orthology)	AARS1 ASPM WDR62	1.66e-03	32	217	3	DOID:10907 (implicated_via_orthology)
Disease	alcoholic liver cirrhosis (is_marker_for)	SERPINF1 TLR9	1.87e-03	9	217	2	DOID:14018 (is_marker_for)
Disease	familial hypertrophic cardiomyopathy (is_implicated_in)	ALPK3 MYBPC3	1.87e-03	9	217	2	DOID:0080326 (is_implicated_in)
Disease	Subarachnoid Hemorrhage	UNC5B THSD1	1.87e-03	9	217	2	C0038525
Disease	total blood protein measurement	RREB1 DYSF ZBTB7A USP4 MICAL3 ARAP1 DGKD KMT2D TXLNB ARHGAP45	1.91e-03	449	217	10	EFO_0004536
Disease	lifestyle measurement, maximum cigarettes per day measurement	UNC5B NPAS3 MGRN1 ARHGEF10L TBX18	2.12e-03	122	217	5	EFO_0009264, EFO_0010724
Disease	Pseudohypoaldosteronism, Type I	GNAS WNK4	2.33e-03	10	217	2	C0268436
Disease	Pseudohypoaldosteronism	GNAS WNK4	2.33e-03	10	217	2	C0033805
Disease	Hyperpotassemia and Hypertension, Familial	GNAS WNK4	2.33e-03	10	217	2	C2713447
Disease	Pseudohypoaldosteronism, Type I, Autosomal Recessive	GNAS WNK4	2.33e-03	10	217	2	C1449843
Disease	Pseudohypoaldosteronism, Type II	GNAS WNK4	2.33e-03	10	217	2	C1449844
Disease	Pseudohypoaldosteronism, Type I, Autosomal Dominant	GNAS WNK4	2.33e-03	10	217	2	C1449842
Disease	Mitral valve prolapse	ALPK3 FBXO46 LTBP3	2.34e-03	36	217	3	HP_0001634
Disease	breast cancer (is_marker_for)	MAPT MAP3K1 TLR9 KMT2D ZFHX3 PLPP4	2.55e-03	185	217	6	DOID:1612 (is_marker_for)
Disease	Osteogenesis imperfecta type III (disorder)	SERPINF1 P3H1	2.83e-03	11	217	2	C0268362
Disease	Drugs used in diabetes use measurement	RREB1 ZZEF1 FGFR4 ARAP1 CLEC14A ZFHX3 LTBP3	2.91e-03	255	217	7	EFO_0009924
Disease	body surface area	PDE4C RREB1 AXIN1 PTPRG FGFR4 GNAS AATK MICALL2 ANKRD11 ZFHX3 LTBP3 ECE2	3.04e-03	643	217	12	EFO_0022196
Disease	neutrophil count	RIN3 CEL TSPOAP1 MAPT RREB1 CIC STAC2 ADRB1 TMCC2 ARHGAP25 FGFR4 FLVCR1 ZNF316 PLEKHG2 HIVEP3 AATK GTF3C1 MICAL2 ANKRD11 ARHGAP45	3.15e-03	1382	217	20	EFO_0004833
Disease	Mitral valve prolapse, response to surgery	ALPK3 LTBP3	3.38e-03	12	217	2	EFO_0009951, HP_0001634
Disease	lung non-small cell carcinoma (is_implicated_in)	MAP3K1 FGFR4 KMT2D SMARCA4 ZFHX3	3.72e-03	139	217	5	DOID:3908 (is_implicated_in)
Disease	mean platelet volume	RIN3 PCNX3 GADD45A STAC2 TMCC2 RIPOR1 GNAS ARAP1 SHANK3 SCARF1 PRICKLE3 ANKRD11 ARHGAP45 PRDM16 MYBPC3 RAB11FIP3	3.77e-03	1020	217	16	EFO_0004584
Disease	Osteogenesis Imperfecta	SERPINF1 P3H1	3.98e-03	13	217	2	C0029434
Disease	advanced glycosylation end product-specific receptor, soluble measurement	PRRT1B PRDM16	3.98e-03	13	217	2	EFO_0020131
Disease	mean arterial pressure	PCNX3 ZNF831 REXO1 TTBK1 ADRB1 GNAS HIVEP3 PRSS42P ZFHX3 PRDM16	4.06e-03	499	217	10	EFO_0006340
Disease	high grade glioma (implicated_via_orthology)	FGFR4 WDR62 BCAN	4.16e-03	44	217	3	DOID:3070 (implicated_via_orthology)
Disease	esophagus squamous cell carcinoma (is_implicated_in)	MAP3K1 FGFR4 KMT2D	4.43e-03	45	217	3	DOID:3748 (is_implicated_in)
Disease	Malignant neoplasm of salivary gland	SERPINF1 ASPM MARCKS	4.43e-03	45	217	3	C0220636
Disease	Hypodontia	EDARADD LTBP3	4.62e-03	14	217	2	C0020608
Disease	disorder of pharynx	DYSF ZBTB7A CARMIL2	4.72e-03	46	217	3	MONDO_0020592
Disease	reticulocyte count	MAPT RREB1 MAP3K1 STAC2 ZNF469 ADRB1 ATP11B TMCC2 USP4 FLVCR1 SCARF1 USP10 FOXP4 MICAL2 SLC19A1 ARHGAP45	4.75e-03	1045	217	16	EFO_0007986
Disease	Salivary Gland Neoplasms	SERPINF1 ASPM MARCKS	5.01e-03	47	217	3	C0036095
Disease	anemia (implicated_via_orthology)	SLC4A3 SLC4A2	5.31e-03	15	217	2	DOID:2355 (implicated_via_orthology)
Disease	serum non-albumin protein measurement	DYSF ZBTB7A PHLPP1 ARAP1 CARMIL2 TXLNB IL21R ARHGAP45	5.48e-03	361	217	8	EFO_0004568
Disease	lymphocyte count	CEL RREB1 ZNF831 ZBTB7A ZNF469 ADRB1 MCM3AP PHLPP1 RIPOR1 USP4 MICAL3 SKAP2 RAD9A CARMIL2 FLVCR1 DGKD SLC45A3 ANKRD11 LTBP3 ARHGAP45	5.92e-03	1464	217	20	EFO_0004587
Disease	syndromic intellectual disability (implicated_via_orthology)	UBE2A PDZD8	6.04e-03	16	217	2	DOID:0050888 (implicated_via_orthology)
Disease	primary autosomal recessive microcephaly (is_implicated_in)	ASPM WDR62	6.04e-03	16	217	2	DOID:0070296 (is_implicated_in)
Disease	cathepsin L1 measurement	PIK3R2 ADGB	6.04e-03	16	217	2	EFO_0010619
Disease	Adenoid Cystic Carcinoma	SERPINF1 ASPM FGFR4 MARCKS	6.44e-03	100	217	4	C0010606
Disease	spontaneous preterm birth	SLC39A11 NPAS3 PTPRG NHSL1	6.66e-03	101	217	4	EFO_0006917
Disease	eosinophil count	RIN3 CEL MAPT DYSF ZBTB7A PIK3R2 SKAP2 LTBP4 CARMIL2 SHC1 FBXO46 HIVEP3 SLC45A3 WDR6 TNFRSF8 HELZ2 ANKRD11 SMARCA4 LTBP3 ARHGAP45	7.04e-03	1488	217	20	EFO_0004842
Disease	hepatocellular carcinoma (is_marker_for)	SERPINF1 MAP3K1 AXIN1 ASPM FGFR4 TLR9 ZFHX3	7.12e-03	301	217	7	DOID:684 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
TEALASPGPDGDSSP	PTPRG	556	P23470
SEPGNLSSAAPLPDG	ADRB1	11	P08588
SDSEGDEGLPAPPKA	ERFL	331	A0A1W2PQ73
SSSLSEEPELSGGPP	ESYT1	931	Q9BSJ8
GADSFCTPEPESLGP	SLC4A2	11	P04920
FSIGSDEDDSPGLPG	SLC4A3	166	P48751
PLPLPPDSDSDSDAG	HTR6	371	P50406
TDDGSLSEETPAGPP	AKT1S1	151	Q96B36
EFPSPLGGPEATGEA	CARD10	481	Q9BWT7
LSGEELCPSSAPGAP	CARD10	881	Q9BWT7
LVPGVPGPSSEAEDD	ARHGEF10L	16	Q9HCE6
PGPSSEAEDDPGEAF	ARHGEF10L	21	Q9HCE6
GPEDDLDLGPFSLPE	ANKRD11	2126	Q6UB99
SISPPADGSEEGSPL	CACNA1E	2181	Q15878
GEGAPAPESSGEPAE	AKAP8	591	O43823
APESSGEPAEDEGPT	AKAP8	596	O43823
GIPPGSDLPSVSETD	ADGB	536	Q8N7X0
FSPTDSGEEPGQLSP	CDK18	61	Q07002
APEEDPATEGGATPV	CARMIL2	1076	Q6F5E8
PGADSPPGTALELEE	C2orf27A	31	P0DPF5
DLSPDGPRSSEGPLS	FGFR4	571	P22455
PGEALTGLPAATPEE	ALPK3	1346	Q96L96
DNATEALPADSGPGP	AFAP1L2	566	Q8N4X5
APGADSPPGTALELE	CDRT15P3	36	P0DPF6
GPSELEAPAPGGSSE	APLP1	491	P51693
ALGEAEPPGPVDATD	CCNK	381	O75909
GSKASPDPDLDPDLS	DPH2	221	Q9BQC3
DSETAPVPPTGDSGA	CEL	576	P19835
TDPGLDSALEPSGDP	CAMSAP1	1146	Q5T5Y3
ATSAPGAEGLEPPAA	CGAS	96	Q8N884
LGEPDSAGAGEPPAT	DMWD	101	Q09019
GPAAEEEASSPPVLS	ASPM	26	Q8IZT6
LPGTSSAAPDLEGPE	ASXL1	466	Q8IXJ9
SAAPDLEGPEFPVES	ASXL1	471	Q8IXJ9
STAPDIPSLVGEAPG	ANKRD63	331	C9JTQ0
DPGSLPPLDSEDLFQ	ETV4	41	P43268
PQGPSPVLAEDSEGE	RAD9A	376	Q99638
DAGDELSLSPSPEGL	TSPOAP1	771	O95153
QSPGLDEPAPGAAAD	RAB11FIP3	51	O75154
GPPEPAQESLSGSES	P3H1	716	Q32P28
PANLESFGGEDPRPE	KASH5	141	Q8N6L0
SPGRDLPPFEDESEG	MCM2	41	P49736
SSLTDEGIGADPEPP	ARHGEF17	641	Q96PE2
LAESSLPAGPAPEEG	HECW2	536	Q9P2P5
QPGASPLPDGESEAS	BCAN	516	Q96GW7
PGESADPGPFVEDGT	CASKIN1	1081	Q8WXD9
PGASPAPDEDAEAAG	OGFRL1	61	Q5TC84
SSFSGSEGEDPRPEP	KRBA1	646	A5PL33
EVLSPPSDSGGPDGS	MICAL3	1671	Q7RTP6
LYGPGSEGTPPSLED	ARHGAP45	246	Q92619
PLSISDSDSGLDPGP	ARHGAP45	621	Q92619
DSDPVPLAPGAADSD	MAP1S	796	Q66K74
GDPNEAPSPDTLLGA	NCKAP5L	306	Q9HCH0
PEPALEPESLDFSGA	NPW	121	Q8N729
SEDVDAPPPLGGAEL	MGRN1	471	O60291
PGDGEVSPSTEDAPF	MCM3AP	521	O60318
PPEDGERPSGSSYLE	KCNG4	316	Q8TDN1
SVGGAEAPALEPPSA	FOXI2	211	Q6ZQN5
DSSAGGDFPPPAEVE	HEXIM1	96	O94992
DAPETPVEGGASPDA	ECE2	26	P0DPD6
PVDGTASAEGREPSP	NHSL1	1586	Q5SYE7
SALEEAGAPAPGRPS	MICALL2	461	Q8IY33
SEAELPASPDAGVPS	PCNX3	341	Q9H6A9
DSPATAPGPDDAEGT	FBXO46	426	Q6PJ61
EAEGGRPPAATSPAE	JRK	446	O75564
DLLGDEPPSSTNTPG	PDZD4	296	Q76G19
DEEPSGAAPEGGATP	PDZD8	66	Q8NEN9
AEATEEAAPEGPGSP	PERCC1	66	A0A1W2PR82
PAASGDSDDDEPPPL	PGRMC1	51	O00264
TELLSPEAGPDPGDL	PDE4C	691	Q08493
ALEDPATPPASEGES	GPR152	441	Q8TDT2
PEGSAQTPAAPLDGA	KREMEN2	336	Q8NCW0
PVEVFESSLSDPGPG	LMTK2	506	Q8IWU2
PAPEGTADSEPATTG	LMTK2	1046	Q8IWU2
DDVGAPVEPLPSNGS	FOXP4	606	Q8IVH2
TPAPPDLTLGEGEEA	PGGHG	181	Q32M88
ADEPTSGAPAPQELG	GOLGA2	911	Q08379
PFLEEAPSASLPGAE	INSM2	36	Q96T92
DSAPSLPLEGITEGP	PLPP4	256	Q5VZY2
APAGPASDTEEEEPG	CASKIN2	921	Q8WXE0
DASPGEDRTPPGLAA	HCN4	136	Q9Y3Q4
GQEPLPSPEGTFDAV	METTL27	121	Q8N6F8
GDIEEAPAEAGSPSP	PPP1R37	16	O75864
ADPEGSVEADGPAQP	PRR20D	31	P86480
EAAGATGDAIEPAPP	MARCKSL1	56	P49006
TGDAIEPAPPSQGAE	MARCKSL1	61	P49006
ADPEGSVEADGPAQP	PRR20A	31	P86496
ADPEGSVEADGPAQP	PRR20B	31	P86481
GTSTELAPATGPEEP	PRICKLE3	411	O43900
DGSEPSPDFPALLVE	PIK3R2	271	O00459
PSLPVGSDSEGPENE	RBBP8NL	386	Q8NC74
GLAVPTPSVPDDFAD	C6orf132	91	Q5T0Z8
PDDPPDRGTGLSASQ	BRME1	191	Q0VDD7
TSTAAPEAGEDEGPP	DNLZ	156	Q5SXM8
DTLAEDKPGPGPFSD	CHD6	2581	Q8TD26
EAPGEPSAGSSEEAP	DDX51	106	Q8N8A6
GEDTTETAPAPGTPA	GAS2L1	181	Q99501
TDAGPAASEGAEQPP	GADD45A	106	P24522
PAAEGEGTPTQPASE	DEK	6	P35659
LDLGYEPEGSASPTP	AXIN1	66	O15169
EAGEPTPGLSDTSPD	BLOC1S6	21	Q9UL45
AGAETPGAESSPLPL	FLVCR1	86	Q9Y5Y0
EAPAEGEAAEPGSPT	MARCKS	106	P29966
TGALPPLAPEGDSVA	LTBP3	166	Q9NS15
GEPEEVSGALSPPSA	GPR173	6	Q9NS66
EPEEPPEGGSYAGSL	LTBP4	1511	Q8N2S1
PPPTIAEEAEDGDGS	DGKD	566	Q16760
ENGFPDSTGDPLPEI	EDARADD	76	Q8WWZ3
SPVECDFTSPGDEGP	IL21R	501	Q9HBE5
DSASPDLGPRGPDLA	EPS8L1	236	Q8TE68
SEPTPEDALGGSAVP	FAM215A	36	Q9Y5M1
DLLTPPAPDGDGRTA	HELZ2	16	Q9BYK8
EDPSSGTGLPREPAL	FAM236C	36	P0DP71
EDPSSGTGLPREPAL	FAM236D	36	A0A1B0GTK5
PPPLDISSDGDVDAT	BEAN1	121	Q3B7T3
TEPLPETPEAASGAA	C4orf54	491	D6RIA3
GLSGDALSSPSAPEP	SEC14L1	216	Q92503
DPEGPALLFPESELS	SLC39A11	126	Q8N1S5
ESPSPQGGPDDVSLL	DYSF	1436	O75923
TPAAPPATLGEGSAD	EHMT1	171	Q9H9B1
GPEPELSPITEGSEA	PPP1R13L	561	Q8WUF5
APEEGSLDLEPGPQS	PKD1L1	1031	Q8TDX9
IPFPRGEDGDGPSSD	MAP3K9	701	P80192
DEGPTAAAAPEGAVP	HOXA7	191	P31268
AAIGTLEGSPPDEPT	MICAL2	1101	O94851
PASSPLADSGPDDLA	ARHGAP30	481	Q7Z6I6
LSLPPQGTSDGPEDT	RIN3	411	Q8TB24
EPPDQSFRTGSPGDA	PLEKHM2	431	Q8IWE5
DDLPTDFEGSLGGPP	RNF150	336	Q9ULK6
PDSGASSPAAAEPGE	MAP3K1	131	Q13233
ESEGLAPQGAAPASP	SYDE1	136	Q6ZW31
LEPGSLGGSDTPEPS	SYT3	146	Q9BQG1
PEDPTEVPGGFLSDL	QARS1	701	P47897
GPNASPTVGPDEDAF	REXO1	131	Q8N1G1
EETEPSAPSAGGGPD	SKOR1	676	P84550
ASGPGPDTGPDSELS	SPAG8	196	Q99932
PASRAPSEEGEGLPA	RNF157	556	Q96PX1
PSEEGEGLPAESPDS	RNF157	561	Q96PX1
DTDGPISLDVPDGAP	TMCC2	266	O75069
SEAPDSLNGPLGPSE	SMG5	546	Q9UPR3
GPAEGPAEPAAEASD	TMEM132A	516	Q24JP5
DALPDSPTPATGGEV	AATK	821	Q6ZMQ8
ADLPEGVAVSGPSPA	RHOT2	526	Q8IXI1
GTLEPDAAAATPAAP	RFLNB	56	Q8N5W9
DDPFAGPPDTISLAS	SKAP2	76	O75563
DPDSGATPEDPDSGT	GNAS	401	Q5JWF2
EGGAAASPPPDAELA	PRR36	1141	Q9H6K5
GPSAPASGEEQPLDL	PRDM16	791	Q9HAZ2
GPDPDVPGTDEASSA	NR1H2	41	P55055
ADPEGSVEADGPAQP	PRR20C	31	P86479
ADPEGSVEADGPAQP	PRR20E	31	P86478
TPAIGPDGEPLDETS	SMARCA4	596	P51532
DDEVSGPSAPGVDPS	SPDYE10	36	P0DUX0
DDEVSGPSAPGVDPS	SPDYE11	36	P0DTA3
DDEVSGPSAPGVDPS	SPDYE8	36	P0DUD1
IPDSVLTPPGADGAA	NPAS3	711	Q8IXF0
EDEGPLNLTSGPEPA	WIZ	1026	O95785
PEAAGPEPSSSGEET	FAM13C	376	Q8NE31
DDPPLAGPKDTSTPD	PRR12	1406	Q9ULL5
ASLEPSAEIPEGSPE	SSC5D	736	A1L4H1
DPGEPSGLETLKDTP	SULT1A4	86	P0DMN0
DPGEPSGLETLKDTP	SULT1A3	86	P0DMM9
TGPEEAEAPESFPAA	SCARF1	636	Q14162
AALGPTEPAEGLSAP	SLC45A3	221	Q96JT2
DPPPGTDSGIEEVDS	SHANK1	1666	Q9Y566
DLESLRPPSAEPGGS	SSH3	251	Q8TE77
PEGTSEGTPDEAAPL	ANKRD30BL	226	A7E2S9
VGDADGESPEPAPAA	B4GALNT4	786	Q76KP1
LPDLSPDEPSEALGF	ADD1	641	P35611
FSGDPEAPTPLALAE	ARAP1	691	Q96P48
ASGPPGEPRLDSETE	CIC	131	Q96RK0
PGLESDPEPAALGSS	CLEC14A	441	Q86T13
LVPEGPTPDSSEGNL	ATP11B	436	Q9Y2G3
ASPVEAEGTPEPGAE	PITPNM1	381	O00562
DADGLAPDVPLPADG	TNRC18	1106	O15417
LALPDDDGSDDSSPP	RNF149	346	Q8NC42
PVGQLDSSPSLPDGD	SHF	231	Q7M4L6
LPDGDRDISGPASPL	SHF	241	Q7M4L6
GDTAPPDLCDPGSLT	USP42	811	Q9H9J4
PDLCDPGSLTGDASP	USP42	816	Q9H9J4
EPELTSAGAAQPEGP	TM2D2	41	Q9BX73
PGPIDNSGLFSDPES	USP4	66	Q13107
ELKDFPPGAEPSTSG	TTBK1	551	Q5TCY1
PSPPPAEDDSDGDSF	ZXDC	61	Q2QGD7
PEEGSPDPDSTGALV	SERPINF1	26	P36955
VPVSELLDDPSGPAG	AARS1	701	P49588
PTGPDLDTALPGTAE	RNF225	266	M0QZC1
GDFTAPESTGDPEKP	RAPGEF1	526	Q13905
TDGSEPAPAPVADGD	SAMD4B	456	Q5PRF9
EGSAPGADLPSLQPS	SHANK3	1036	Q9BYB0
DGASTAEEGPQPAPE	RREB1	1426	Q92766
GDLAPAPVDTPSSED	TLR9	451	Q9NR96
PSPGEKALGTPEDLD	TNS4	81	Q8IZW8
SSEGDEGAALPPPAG	TBX18	66	O95935
DDEVSGPSAPGVDPS	SPDYE12	36	P0DUX1
DDEVLGPSAPGVDPS	SPDYE13	36	A0A494C0Z2
DDEVLGPSAPGVDPS	SPDYE14	36	P0DUD3
DDEVLGPSAPGVDPS	SPDYE15	36	P0DUD4
DDEVSGPSAPGVDPS	SPDYE17	36	P0DUD2
DDEVLGPSAPGVDPS	SPDYE18	46	P0DV79
DDEVLGPSAPGVDPS	SPDYE21	46	A0A494C086
DDEVLGPSAPGVDPS	SPDYE5	46	A6NIY4
EEGPGDSASPVFTAP	STAC2	251	Q6ZMT1
VFTAPAESEGPGPEE	STAC2	261	Q6ZMT1
PSLPGSPGEEASALS	ARHGAP25	506	P42331
SGPVPPEDDASGSES	THSD1	501	Q9NS62
PLSPEDSLGAVGPAS	SLC19A1	501	P41440
TSGEDAERSPPPDGQ	SNX21	91	Q969T3
PLGGEYSSEEPGPSS	HIVEP3	596	Q5T1R4
LQEDPPAGVSGAPSE	UBE2A	16	P49459
ESLPLQDASPAGGPS	TNFRSF8	481	P28908
PLLSEEGGENPEASP	PRSS42P	36	Q7Z5A4
STEIPASEPDGPSVG	MAPT	276	P10636
GSEVLPDSFPSAPAE	UNC5B	31	Q8IZJ1
QPDDLEPGSEGPDLT	WDR6	726	Q9NNW5
SAGGPPVSPLADLSD	PRAG1	561	Q86YV5
DVFADEEPSGPRGPS	ZNF469	866	Q96JG9
LPTQPSFEEGGDPTL	ZNF469	2861	Q96JG9
ALERPENEASPGSPG	ZNF469	3546	Q96JG9
GPTEDELSLPEGPSV	WDR62	1031	O43379
EEAPSAASPGTEPTG	VWA5B2	591	Q8N398
PGETAAAAGPEDTDP	ZNF316	521	A6NFI3
ADASPPTGLPDAEDS	ZZEF1	2046	O43149
DIVPDSPFPGALGSD	USP10	221	Q14694
GSTASDEPPPGALSE	PHLPP1	1491	O60346
GLPLTDDAPPGATEE	SLC35G1	16	Q2M3R5
DDEVSGPSAPGVDPS	SPDYE9	36	A0A494C191
DLEDAGPPTLDPSGT	PLEKHG2	526	Q9H7P9
PQAEAEGGSDAEPPS	TXLNB	561	Q8N3L3
SPASGPSPGEADSIL	ZNF831	991	Q5JPB2
PLEGSSSEDSPPEGQ	GTF3C1	1836	Q12789
PSSGPLDEEGAVAPV	RIPOR1	426	Q6ZS17
LAPVAAPAGSGDPDD	RARRES1	31	P49788
VESSSDAAPGPGRPE	ZNF335	6	Q9H4Z2
PQDEGSEPPTTAAAG	ZNF579	146	Q8NAF0
AGGSEPAPEDAPAQA	PRRT1B	66	A0A1B0GWB2
PTPEPSGSLGAALDS	TTC9B	46	Q8N6N2
DSARPELPDSAVGPG	WNK4	121	Q96J92
LEEGASGSTPPEELP	SHC1	21	P29353
ASLSEAAPEPGDSPG	ZBTB7A	281	O95365
PPAGSSGSAEPEEDE	ZFTA	31	C9JLR9
PDGSEDLEPLAGGSP	ZNF473	56	Q8WTR7
DLEPLAGGSPEATSP	ZNF473	61	Q8WTR7
EEALPAGSAAGPEQP	ZFHX3	376	Q15911
PSPADPGSVREDSGF	ZFHX3	1346	Q15911
PVGSDPDFQPELSGA	TXNL1	6	O43396
DTAPLDGIDAPGSQP	KMT2D	1121	O14686
SLDEGGPEPEPSLSD	N4BP3	176	O15049
APGEAPAPAAELGES	MYBPC3	116	Q14896